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ABSTRACT 
Perkinsus marinus, the causative agent of Dermo disease in eastern oyster 
Crassostrea virginica has been a great hurdle for oyster population restoration along the 
atlantic and gulf coasts of USA. Iron was shown to be an essential element for P. marinus 
growth and virulence, but iron uptake pathways have not been elucidated.  
 The Natural Resistance-Associated Macrophage Protein (Nramp), an iron 
transporter initially identified in the mouse as a marker for resistance to intracellular 
pathogens, was also proposed as a potential virulence factor for intracellular pathogens. An 
Nramp homologue was identified by our laboratory in P. marinus (PmNramp1). In this 
study, two other PmNramp isotypes (PmNramp2 and PmNramp3) were identified through 
genome mining followed by molecular characterization. The three PmNramp isotypes are 
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encoded by genes of distinct organization, and are all transcribed in parasite trophozoites 
cultured in defined medium. Transcripts of a number of P. marinus genes, including 
PmNramp isotypes, superoxide dismutases (PmSOD), ascorbate peroxidase (PmAPX) and 
heat shock proteins (PmHSP70 and PmHSP90) display a trans-splicing leader (SL) highly 
similar to that from dinoflagellates. No changes in transcription levels of those genes were 
detected by real-time quantitative reverse transcription PCR (qRT-PCR), under 
iron/manganese overload, iron depletion, and host hemolymph exposure, suggesting a 
constitutive polycistronic transcription in the parasite.  
Functional studies by yeast complementation assays suggested iron uptake 
activity by PmNramp1, but not for PmNramp2 and PmNramp3. Prediction of PmNramp1 
topology by homologous modeling indicated that PmNramp1 is an integral protein with 
12 transmembrane segments (TMS). The central position of the Nramp-specific triplets 
Asp-Pro-Gly (TMS1) and Met-Pro-His (TMS6) in a three-dimensional (3D) arrangement 
formed with TMS3 and TMS8 provided the mechanistic basis for iron acquisition via 
PmNramp1. Site-directed mutagenesis of selected residues in the TMS6 triplets in 
PmNramp1 resulted in loss of complementation of the mutant in yeast. A chimeric 
protein with PmNramp1 N- and C-termini and a PmNramp3 core structure from TMS1 to 
TMS12 actively complemented yeast growth, suggesting that PmNramp3 can function as 
an iron transporter. A phylogenetic analysis indicated that all the three PmNramp 
isotypes are of the archetype Nramp cluster. Protein sequence divergence among 
PmNramp isotypes was not related to diversification of critical functional elements, 
which remained constrained by purifying selection. This result was consistent with the 
function of both PmNramp1 and PmNramp3 as iron transporters in yeast, despite their 
different evolutionary rate and substitution patterns. Subcellular localization of PmNramp 
isotypes in P. marinus trophozoites is in progress. PmNramp3 was shown to localize on 
cell peripheral when the parasite proliferates by binary fission. The data were consistent 
with the previous observation that iron is important for P. marinus growth.  
As the first functional study of Nramp homolog in protozoan parasites, the work 




THE DIVALENT CATION TRANSPORTER NRAMP IN PARASITE 
PERKINSUS MARINUS: GENOMIC, MOLECULAR, STRUCTURAL, FUNCTIONAL 









Dissertation submitted to the Faculty of the Graduate School of the 
University of Maryland, College Park, in partial fulfillment 
of the requirements for the degree of 








Professor Gerardo R. Vasta, Chair 
Professor Mathieu F. Cellier 
Professor Feng Chen 
Professor Isabelle Coppens 
Professor José-Antonio Fernández-Robledo 

















The dissertation project was supported by the NSF grant awarded to Dr. Vasta. I 
would like to thank Dr. Vasta for the opportunity to work in his lab and for his support 
and advice during my Ph.D training process. I also would like to thank my committee 
member Dr. Fernández-Robledo for all the scientific discussions we had about my 
dissertation project. I need to thank my committee member Dr. Cellier for his great effort 
in my dissertation project as a collaborator. I am indebted to my committee members Dr. 
Coppens and Dr. Chen for their time, patience, and dedication to the completion of my 
research work. Furthmore, many thanks to former and present lab members in Dr. Vasta’s 
lab for their support and expertise. Last but not least, I thank my parents and my husband 
for their constant support for making all of these possible.
iii 
 
TABLE OF CONTENTS 
ACKNOWLEDGEMENTS .................................................................................... II 
TABLE OF CONTENTS ...................................................................................... III 
LIST OF TABLES ................................................................................................ IX 
LIST OF FIGURES ............................................................................................... X 
LIST OF ABBREVIATIONS ............................................................................ XIII 
CHAPTER 1 INTRODUCTION AND BACKGROUND INFORMATION ........ 1 
1.1 Introduction ............................................................................................... 1 
Dermo disease and P. marinus ........................................................................ 1 
Importance of iron for Perkinsus marinus survival and virulence ................. 1 
1.2 Background ............................................................................................... 3 
Iron is a critical trace element for both hosts and pathogens .......................... 3 
Host iron metabolism and nutritional immunity ............................................. 4 
Iron acquisition by protozoan parasites ........................................................ 14 
Identification of Nramp as a marker for resistance to infection ................... 33 
Nramp functions in metal homeostasis ......................................................... 34 
Nramp as a potential microbial virulence factor ........................................... 35 
CHAPTER 2 MOLECULAR CHARACTERIZATION OF TWO NOVEL 
NATURAL RESISTANCE-ASSOCIATED MACROPHAGE PROTEIN ISOTYPES 
(PMNRAMP2 AND PMNRAMP3) IN PERKINSUS MARINUS .................................... 39 
iv 
 
SUMMARY ...................................................................................................... 39 
INTRODUCTION ............................................................................................ 40 
MATERIALS AND METHODS ...................................................................... 41 
Perkinsus marinus cultures ........................................................................... 41 
Genome mining ............................................................................................. 41 
Nucleic acid extraction and cDNA cloning and sequencing ........................ 42 
Identification of trans-splicing leader in other genes .................................... 43 
Challenge experiment design ........................................................................ 44 
RNA extraction and reverse transcription ..................................................... 45 
Quantitative PCR .......................................................................................... 46 
RESULTS ......................................................................................................... 48 
Identification of two novel PmNramp isotypes ............................................ 48 
Gene organization of PmNramp isotypes ..................................................... 52 
Amino acid alignment of PmNramp isotypes with human Nramp2 homolog
................................................................................................................................... 54 
PmNramp mRNA is trans-spliced with trans-splicing leader highly identical 
to dinoflagellate splice leader ................................................................................... 57 
Other genes in P. marinus are trans-spliced ................................................. 60 
v 
 
Trans-spliced P. marinus genes show no obvious transcriptional regulation63 
DISSCUSSION ................................................................................................. 83 
CHAPTER 3 PHYLOGENETIC ANALYSIS OF THE PMNRAMP ISOTYPES
........................................................................................................................................... 88 
SUMMARY ...................................................................................................... 88 
INTRODUCTION ............................................................................................ 89 
MATERIALS AND METHODS ...................................................................... 90 
Phylogenetic analysis .................................................................................... 90 
Molecular evolutionary gene analyses .......................................................... 92 
RESULTS AND DISCUSSION ....................................................................... 99 
Taxonomic distribution of Nramp in eukaryotes .......................................... 99 
Phylogeny of Perkinsus Nramp1-3 proteins ............................................... 107 
Analysis of Perkinsus Nramp1-3 gene evolution ....................................... 110 
Detailing evolutionary patterns of Perkinsus Nramp1-3 genes domains.... 111 
CHAPTER 4 FUNCTIONAL CHARACTERIZATION OF THE PMNRAMP 
ISOTYPES ...................................................................................................................... 114 
SUMMARY .................................................................................................... 114 
INTRODUCTION .......................................................................................... 114 
MATERIALS AND METHODS .................................................................... 115 
vi 
 
Yeast strains and plasmid............................................................................ 115 
Culture and transformation of yeast cells ................................................... 116 
Transformation and expression of PmNramp isotypes in transformed yeast
................................................................................................................................. 116 
Construction of chimeric PmNramp2 and PmNramp3 ............................... 117 
IFAs to detect PmNramp protein expression in fet3fet4 ............................. 121 
Yeast complementation assay of transformed fet3fet4 ............................... 122 
Complementation assay of yeast smf1smf2................................................. 122 
RESULTS ....................................................................................................... 123 
Expression of PmNramp isotypes in fet3fet4 .............................................. 123 
PmNramp1 complements the growth of fet3fet4 ........................................ 126 
Fet3fet4 complementation assay of chimeric PmNramp2 and PmNramp3 129 
Yeast complementation assay in smf1smf2 ................................................. 132 
DISCUSSION ................................................................................................. 135 
CHAPTER 5 STRUCTURAL AND MECHANISTIC STUDIES OF THE 
PMNRAMP ISOTYPES ................................................................................................. 137 
SUMMARY .................................................................................................... 137 
INTRODUCTION .......................................................................................... 137 
vii 
 
MATERIALS AND METHODS .................................................................... 140 
Structural analysis of PmNramp1 by homology modeling ......................... 140 
Site-directed mutagenesis ........................................................................... 140 
RESULTS ....................................................................................................... 141 
Functional features predicted from protein sequence structural modeling 
analysis .................................................................................................................... 141 
Site-directed mutagenesis of PmNramp1 predicted functional residues .... 148 
DISCUSSION ................................................................................................. 153 
CHAPTER 6 SUBCELLULAR LOCALIZATION OF THE PMNRAMP 
ISOTYPES ...................................................................................................................... 158 
SUMMARY .................................................................................................... 158 
INTRODUCTION .......................................................................................... 158 
MATERIALS AND METHODS .................................................................... 163 
Generation of PmNramp antibodies ............................................................ 163 
Western blot analysis of PmNramp isotypes .............................................. 166 
IFAs in P. marinus cells.............................................................................. 166 
RESULTS ....................................................................................................... 167 
Western blot on parasite lysates using purified PmNramp IgG .................. 167 
viii 
 
Localization of PmNramp3 in log-phase P. marinus trophozoites ............. 171 
DISCUSSION ................................................................................................. 175 
CHAPTER 7 SUMMARY AND FUTURE DIRECTIONS ............................... 179 
Functional studies of PmNramp isotypes ................................................... 179 
Domain swapping as a novel approach for functional studies of protozoan 
Nramp in heterologous systems .............................................................................. 181 
P. marinus and oyster hemocyte interaction: the “tug-of-war” for iron ..... 181 
Other potential iron uptake pathways in P. marinus ................................... 182 
P. marinus genomic organization and post-transcription regulations ........ 182 
BIBLIOGRAPHY ............................................................................................... 185 
ix 
 
LIST OF TABLES 
TABLE 1. COMMON PROTOZOAN PARASITES AND THEIR PARASITIC 
NICHES IN HOST ........................................................................................................... 17 
TABLE 2. THE COMPOSITION OF PERKINSUS MARINUS CULTURE 
MEDIUM .......................................................................................................................... 42 
TABLE 3. PRIMERS USED FOR AMPLIFYING PERKINSUS NRAMP GENES
........................................................................................................................................... 42 
TABLE 4. PRIMERS USED IN TESTING OF TRANS-SPLICING LEADER IN 
OTHER GENES ............................................................................................................... 44 
TABLE 5 PRIMERS USED IN QUANTITATIVE PCR .................................... 47 
TABLE 6 IDENTITY AND SIMILARITY OF PMNRAMP ISOTYPES .......... 54 
TABLE 7. TAXONOMIC DISTRIBUTION OF KNOWN EUKARYOTIC 
NRAMP HOMOLOGS ................................................................................................... 104 
TABLE 8. PRIMERS USED IN N- AND C-TERMINUS SWAPPING AND 
YEAST COMPLEMENTATION ................................................................................... 117 
TABLE 9. SITE DIRECTED MUTAGENESIS OF PMNRAMP1 ................... 141 
x 
 
LIST OF FIGURES 
FIG. 1.  MAMMALIAN IRON METABOLISM IS REGULATED BY INNATE 
IMMUNITY. ..................................................................................................................... 12 
FIG. 2. SUMMARY OF IRON UPTAKE PATHWAYS IDENTIFIED IN 
EXTRACELLULAR PROTOZOAN PARASITES. ........................................................ 26 
FIG. 3. SUMMARY OF IRON UPTAKE PATHWAYS IDENTIFIED IN 
LEISHMANIA AMASTIGOTES. ..................................................................................... 32 
FIG. 4. RT-PCR ANALYSIS OF PMNRAMP ISOTYPES IN P. MARINUS 
TROPHOZOITES. ............................................................................................................ 51 
FIG. 5. GENE ORGANIZATION OF PMNRAMP HOMOLOGS. ..................... 53 
FIG. 6. MULTIPLE ALIGNMENT OF DEDUCED AMINO ACID 
SEQUENCES OF PMNRAMP1, PMNRAMP2 AND PMNRAMP3 WITH HUMAN 
NRAMP2 (HSNRAMP2). ................................................................................................ 56 
FIG. 7. THE CONSERVED SL SEQUENCE FROM P. MARINUS NRAMP 
MRNAS. ........................................................................................................................... 59 
FIG. 8. THE CONSERVED SL SEQUENCE FROM OTHER GENES IN P. 
MARINUS ......................................................................................................................... 62 
FIG. 9. EXPRESSION OF PMNRAMP1 UPON DIFFERENT TREATMENTS.
........................................................................................................................................... 66 
FIG. 10. EXPRESSION OF PMNRAMP2 UPON DIFFERENT TREATMENTS.
........................................................................................................................................... 68 
FIG. 11. EXPRESSION OF PMNRAMP3 UPON DIFFERENT TREATMENTS.
........................................................................................................................................... 70 
FIG. 12. EXPRESSION OF PMSOD1 UPON DIFFERENT TREATMENTS. .. 72 
FIG. 13. EXPRESSION OF PMSOD2 UPON DIFFERENT TREATMENTS. .. 74 
xi 
 
FIG. 14. EXPRESSION OF PMAPX1 UPON DIFFERENT TREATMENTS. .. 76 
FIG. 15. EXPRESSION OF PMAPX2 UPON DIFFERENT TREATMENTS. .. 78 
FIG. 16. EXPRESSION OF PM18S UPON DIFFERENT TREATMENTS. ...... 80 
FIG. 17. EXPRESSION OF PMHSP70 AND PMHSP90 TRANSCRIPT UPON 
TEMPERATURE CHANGES. ......................................................................................... 82 
FIG. 18. AMINO ACID ALIGNMENT OF THE THREE PMNRAMP 
ISOTYPES ........................................................................................................................ 95 
FIG. 19. CODON-BY-CODON CDNA ALIGNMENT OF PMNRAMP 
ISOTYPES ........................................................................................................................ 98 
FIG. 20. SIMPLIFIED PHYLOGENY OF PMNRAMP1-3 .............................. 102 
FIG. 21.  PHYLOGENETIC ANALYSES OF SEQUENCES DERIVED FROM 
TAXONOMICALLY DIVERSE UNICELLULAR EUKARYOTES DEMONSTRATE 
PREVALENCE OF PROTOTYPE NRAMP (PN). ....................................................... 106 
FIG. 22. DETAILED PHYLOGENY OF P. MARINUS NRAMP HOMOLOGS 
(PMNRAMP1-3) DEMONSTRATES THEY BELONG TO THE NRAMP 
ARCHETYPE II GROUP. .............................................................................................. 109 
FIG. 23. N- AND C-TERMINI SWAPPING OF PMNRAMP1 TO PMNRAMP2 
AND PMNRAMP3 ......................................................................................................... 120 
FIG. 24. TRANSFORMATION AND EXPRESSION OF PMNRAMP 
ISOTYPES IN FET3FET4. ............................................................................................ 125 
FIG. 25. YEAST COMPLEMENTATION ASSAY OF PMNRAMP ISOTYPES 
IN FET3FET4 ................................................................................................................. 128 
FIG. 26. COMPLEMENTATION OF IRON DEFICIENCY PHENOTYPE OF 
YEAST FET3FET4 MUTANT BY CHIMERIC PMNRAMP3. ................................... 131 
xii 
 
FIG. 27. COMPLEMENTATION ASSAY OF YEAST STRAIN SMF1SMF2 IN 
SOLID MEDIUM. .......................................................................................................... 134 
FIG. 28. DISPLAY OF PREDICTED STRUCTURE BY ALIGNMENT OF 
PMNRAMP ISOTYPES WITH HUMAN NRAMP2. ................................................... 145 
FIG. 29.  HYPOTHETIC MODEL FOR TRANSMEMBRANE SYMPORT OF 
DIVALENT METALS AND PROTONS VIA PMNRAMP1. ...................................... 147 
FIG. 30. COMPLEMENTATION ASSAYS OF YEAST FET3FET4 MUTANT 
AFTER MUTATIONS OF KEY RESIDUES IN PMNRAMP1. ................................... 152 
FIG. 31. A DIAGRAMMATIC DRAWING OF CELL CYCLE OF CULTURED 
P. MARINUS. .................................................................................................................. 162 
FIG. 32. RABBIT ANTISERUM WAS RAISED AGAINST PEPTIDES 
PREDICTED TO BE THE LOOPS BETWEEN TMS7 AND TMS8. .......................... 165 
FIG. 33. WESTERN BLOT ANALYSIS OF PMNRAMP ISOTYPES USING 
PURIFIED IGG .............................................................................................................. 170 
FIG. 34. LOCALIZATION OF PMNRAMP3 IN LOG-PHASE P. MARINUS BY 




LIST OF ABBREVIATIONS 
3D  three-dimensional  
ACO  aconitase 
ApcT  amino acid-polyamine-organocation transporter 
APX  ascorbate peroxidase 
BetP  betaine transporter 
BLAST basic local alignment search tool 
bp  base-pair  
CNS  central nerve system 
Dcytb  duodenal cytochrome-b 
DFO  deferoxamine 
CHO  Chinese hamster ovary 
DME  Dulbecco modified Eagle's 
DMT1  divalent metal transporter 1 
ER  endoplasmic reticulum 
ESTs  expressed sequence tags 
FBS  fetal bovine serum 
FLVCR feline leukemia virus, type C, receptor 
FPN1  ferroportin-1 
GDF15 growth differentiation factor 15 
HAM12 Ham's F12 
HCP1  heme carrier protein-1 
HIFs  hypoxia-inducible factors 
HJV  hemojuvelin 
HO  heme oxygenase 
xiv 
 
Hp  hephaestin 
HSP  heat shock protein 
IRE/IRP iron responsive element/iron responsive protein 
IRP1  iron responsive protein-1 
IRT  iron regulated transporter 
LD  lethal dose 
LeuT  leucine transporter 
Lf  lactoferrin 
LIP  labile iron pool 
LIT  Leishmania iron transporter 
LPS  lipopolysaccharide 
Mhp 1  sodium-benzylhydantoin transport protein 
MntH  manganese transport, H+-dependent 
Nramp  natural resistance-associated macrophage protein 
PCR  polymerase chain reaction 
PGC  polycistronic gene cluster 
PV  parasitophorous vacuole 
QPCR  quantitative PCR 
RACE  rapid amplification of cDNA ends 
RBCs  red blood cells 
RMSD  root mean square deviation 
RNAi  RNA interference 
RNS  reactive nitrogen species 
ROS  reactive oxygen species 
SGLT1 sodium-coupled glucose transporter 
xv 
 
SL  splicing leader 
Slc  solute carrier 
SOD  superoxide dismutase 
STEAP3 six-transmembrane epithelial antigen of the prostate-3 
Tf  transferrin 
TMS  transmembrane segment 
UTR  untranslated region 
VSG   variant surface glycoprotein 




CHAPTER 1 INTRODUCTION AND BACKGROUND 
INFORMATION 
1.1 Introduction  
Dermo disease and P. marinus 
Perkinsus species, are parasites of oysters, abalones, clams, and scallops, and 
have caused substantial damage to these fisheries worldwide [1, 2]. P. marinus is a 
facultative intracellular parasite that causes “Dermo” disease in the eastern oyster C. 
virginica [3]. Over the last 10-15 years, the range of P. marinus infection has extended 
along the Atlantic coast from New Jersey to Maine [4-6] with catastrophic consequences 
for local fisheries and the health of coastal waters [7]. The life cycle of P. marinus 
includes a free-living stage (zoospore) and a non-motile vegetative stage (trophozoite). 
Upon entering the host, most commonly by ingestion during filter-feeding, trophozoites 
are phagocytosed by oyster hemocytes where they are able to survive and proliferate 
inside a phagosome-like structure. Although the infection mechanism has not been fully 
elucidated, a galectin of unique structure plays a significant role in parasite entry into the 
host hemocytes [8]. Migration of infected hemocytes throughout the host tissues leads to 
systemic infection and eventually death [3, 9]. In the environment, transmission of P. 
marinus between oysters likely occurs when released trophozoites from infected oysters 
are filtered by adjacent individuals [7].  
Importance of iron for Perkinsus marinus survival and virulence 
Iron is a critical factor for Perkinsus growth and infection. In the eastern oyster C. 
virginica, the infection intensity of the protozoan parasite P. marinus increases with 
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environmental iron concentrations in a dose-dependent manner [10]. By adding 
deferoxamine (DFO) into the culture medium, the parasite growth was significantly 
inhibited; however, supplementing with the appropriate iron equivalents to saturate the 
DFO can rescue the parasite’s growth [11]. One potential explanation for the importance 
of iron for P. marinus infection is that iron is the cofactor for the enzymes in the 
antioxidant pathways in the parasite. The hypothesis was proposed that P. marinus can 
overcome oyster oxidative burst by degradation of host-originated reactive oxygen 
species (ROS) [12, 13]. The identification of the key elements PmSOD1, PmSOD2, 
PmAPX and PmAPX2 in P. marinus antioxidant pathway [14-16] provided a molecular 
evidence for the ROS detoxification activity in the parasite.  The fact that both the two 
SOD isotypes in P. marinus are iron-dependent indicates a potential connection between 
iron acquisition and P. marinus anti-oxidant pathway function. Despite our long 
acknowledgement of the importance of iron for P. marinus, no iron uptake pathways 
were identified. The research work in the dissertation is essentially the first exploration of 
iron acquisition pathways in this parasite. The outline for the following part of the 
dissertation is as below 
 Background  
o Iron-uptake in host and protozoan parasites 
o role of Nramp in the tug-off war for iron 
 Chapter 2: molecular identification of two other P. marinus Nramp 




 Chapter 3: functional analysis of PmNramp isotypes in the aspects of 
transported substrates and 3D structure 
 Chapter 4: subcellular localization of PmNramp isotypes in P. marinus 
 Chapter 5: phylogeny analysis of PmNramp isotypes 
 Chapter 6: summaries and future directions 
1.2 Background                                                                                 
Iron is a critical trace element for both hosts and pathogens 
Iron is an essential trace element for almost all organisms. Function as enzyme 
cofactor makes iron indispensable in a variety of biological activities, including oxygen 
transport in red-blood animals [17], DNA synthesis [18], electron transport [19] and 
others. The delicate balance orchestrated by iron uptake, transport, storage and release is 
pivotal since this metal can be a double-edged sword due to its redox-activity [20]. 
Therefore, every single taxon has evolved a rigorously controlled iron homeostasis 
system that fits its ecological niche. At the host-pathogen interface, the control of the 
balance becomes more intricate when two highly-evolved iron-acquisition systems 
compete directly with each other. During co-evolution of hosts and pathogens, pathogens 
have evolved efficient iron scavenging machineries to divert iron from host molecules, 
while the hosts have developed coordinated responses to infection, embargoing access to 
endogenous iron reserves. This strategy constitutes the basis of the concept of “nutritional 
immunity” [21, 22].  
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The iron-metabolism systems of host cells have been summarized in recent 
reviews [20, 23-25]. Based on functions, the elements involved in host iron homeostasis 
fall into at least eight categories: redox active (e.g., Dcytb), sensing (e.g., transferrin 
receptor 2), delivery (e.g., transferrin), import (e.g. divalent metal transporter 1, 
transferrin receptor 1), recovery (e.g. haptoglobin), storage (e.g. ferritin), export (e.g. 
ferroportin), metabolic regulation (e.g., intracellular, iron responsive protein 1 and 
endocrine, hepcidin).Some of these functions have been adapted to host defense against 
microbial pathogens. During infections, a large amount of lactoferrin is released for tight 
binding of ferric iron even in acid conditions. Siderocalin, also called lipocalin2, is able 
to interfere the pathogenic siderophores function via direct binding. The host resistance 
marker to intracellular pathogens, Nramp1 is recruited to the phagosomal membrane to 
withdraw iron away from pathogens [20, 23]. 
Host iron metabolism and nutritional immunity 
Mammalian hosts use iron as the oxygen carrying element. Approximately 70% 
of the body iron exists in hemoglobin in red blood cells (RBCs) and erythroid precursors. 
As the biggest iron sink in the body, the iron supply for hemoglobin production in 
erythroid precursors is mostly through the iron delivery molecule Tf (transferrin) that 
undergoes the endocytosis pathway. Two of the other highly-expressed molecules, six-
transmembrane epithelial antigen of the prostate-3 (STEAP3) [26, 27] and DMT1 
(divalent metal transporter) [28] are the ferrireductase and the ferrous iron transporter in 
the endosomes (Fig. 1). Iron delivery to other tissues may involve different molecules, 
such as H- and L-ferritin which allow iron entry into cells via distinct endocytic receptors 
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TIM-2 [29] and Scara5 [30], respectively.  Also DMT1 and Zip14 facilitate non-Tf bound 
iron uptake [31]. 
There are two potential ways for the endosomal iron to reach mitochondria, the 
factory for heme and iron-sulfur cluster synthesis. One way of endosomal iron supply to 
mitochondria comes from low molecular weight complexes in the cytosolic labile iron 
pool (LIP); beside,  protein-to-protein or compartment-to-compartment iron delivery to 
mitochondria was also proposed based on the study in hbd mutant mice [32-35]. It is 
believed that mitochondria have redundant iron transporters and one of the identified 
carriers is mitoferrin [36, 37]. Cytotoxic over-accumulation of free iron or heme is 
avoided in the erythroid precursors by the expression of two isoforms of ferroportin (+/- 
IRE, [38] ) and the heme exporter Feline leukemia virus, type C, receptor (FLVCR) [39, 
40], respectively. 
Mammalian erythroid precursors eventually develop into mature RBCs that have 
no nucleus and little repair capacity [41]. After 100 to 120 days spent in the blood 
circulation, RBCs become senescent. In the absence of infection, macrophages recycle 
iron from senescent RBCs, through erythrophagocytosis, and more generally from effete 
cells (e.g., PMNs, polymorphonuclear neutrophils). Senescent cells are engulfed and 
broken down within macrophages and iron is liberated from heme molecules by heme 
oxygenases (HO1 and HO2). Besides active phagocytosis of senescent cells, 
macrophages are also able to scavenge Tf-bound and Lf (lactoferrin)-bound [42] iron as 
well as hemoglobin-haptoglobin complexes. During hemolysis, haptoglobin binds to 
hemoglobin to prevent oxidative activities [43, 44].  The membrane receptor CD163 can 
interact with the hemoglobin-haptoglobin complex and internalize both molecules 
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through endocytosis. If severe hemolysis happens and haptoglobin is exhausted, CD163 
can scavenge hemoglobin directly through the same pathway [45]. Unless under 
pathological conditions, macrophages normally accumulate little iron, and when plasma 
level is high, the excess is primarily stored in the ferritin of hepatocytes. 
Macrophages expressing the exporter ferroportin-1 (FPN1) release iron into the 
circulation, acting as the recycling factory for ~90% of body iron. This activity 
corresponds to M2 macrophages in terms of activation states [46, 47]. M2 macrophages, 
by definition, stimulated with the Th2 cytokines interleukin 4 (IL4) and/or IL13, are 
functionally distinct from M1 macrophages, stimulated with the Th1 cytokine interferon 
gamma, IFNγ and/or bacterial lipo-polysaccharide (LPS) [48]. M2 macrophages are 
heterogeneous and include immunologically quiescent cells (M0). In steady state 
conditions, these phagocytes contribute to maintain self-tolerance and efficient iron 
recycling though anti-inflammatory circuits that are enforced by lipid ligands of the 
nuclear receptors families PPAR and LXR [49-51] as well as binding of external 
phosphatidyl-l-serine to stereospecific receptors [52, 53]. M2 macrophages are also 
crucial for tissue repair and the resolution phase of inflammatory responses [54]. 
However, sensing infection through activation of pattern recognition receptors 
[e.g., Toll-like receptors (TLRs), NOD-like receptors (NLRs), RIG-I-like receptors 
(RLRs) etc.] activates macrophage microbicidal functions (M1), which are amplified by 
inflammation and the acute phase response.  Notably, M1 macrophages sequester iron by 
secreting hepcidin, reducing FPN1 expression and increasing the synthesis of H-ferritin 
[46, 47] (Fig. 1). Both M1 macrophages and hepatocytes secrete H-ferritin; the presence 
of this acute phase protein has profound immunological consequences because its 
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receptor TIM-2 acts as a negative regulator of Th2 cytokines [29]. Consistent with 
macrophage polarization towards iron recycling vs. iron sequestration, all known iron 
metabolism-related molecules expressed in macrophages are tightly regulated during 
immune responses [25]. These apparently opposite roles of macrophages in iron 
metabolism make them key players in host-pathogen interactions. 
As most of the iron required for erythropoiesis comes from macrophage 
erythrophagocytosis, the remaining portion that is necessary to compensate body losses is 
obtained from diet.  Dietary free iron is acquired through the apical membrane of 
epithelial cells from the small intestine (enterocytes). The duodenal cytochrome-b (Dcytb) 
[55, 56] and possibly other reductases convert ferric iron into ferrous iron ready to be 
transported into the cell by DMT1, also described as Nramp2 [28, 57]. Enterocytes are 
also able to absorb iron from heme molecules using the heme carrier protein-1 (HCP1) 
through the endocytic pathway. When diet is replete with iron, uptake through DMT1 
dominates because HCP1 remains located inside endosomal vesicles, but heme uptake 
provides an alternative pathway in conditions where iron is scarce [58]. After transit 
through enterocytes, iron is relocated to the basal membrane and exported through FPN1 
[59, 60]. Subsequently iron is oxidized by hephaestin (Hp), and released into the 
circulation system in the form of transferrin-bound iron (diferric transferrin, Fig. 1). 
RBCs, macrophages, enterocytes and hepatocytes play different roles in iron 
homeostasis but cellular activities are generally subjected to both endogenous regulators 
and a systemic, integrated control.  Eukaryotic cells rapidly and coordinately regulate 
iron and energy metabolisms by sensing the intracellular free iron status as well as the 
presence of ROS, reactive nitrogen species (RNS) and/or hypoxia through the use of 
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labile 4Fe-4S cluster-protein complexes, such as the cytoplasmic aconitase/iron response 
protein 1 (IRP1) or Fe- and 2-oxoglutarate-dependent dioxygenases [that target hypoxia-
inducible factors (HIFs), and IRP2 for degradation).  Reduction in available iron 
stimulates IRP activities which modulate the stability mRNA encoding iron trafficking 
and storage factors that functions to replenish cellular stores.  Hypoxia (mimicking iron 
deficiency) triggers HIFs activities which reduce the expression of hepcidin in 
hepatocytes [61] and upregulate iron uptake in enterocytes [62]. 
Hepatocytes scavenge circulating iron from Tf, heme and ferritin. Most of iron 
homeostasis proteins, for instance, Tf, haptoglobin and hepcidin are synthesized by 
heptocytes [20]. Identification of hepcidin as the key molecule for systemic regulation of 
iron metabolism was instrumental in understanding the complexity of iron homeostasis 
[63, 64]. Circulating hepcidin binds specifically to FPN1 on the membrane of cells (e.g. 
macrophages, enterocytes and hepatocytes) and triggers intracellular degradation of 
FPN1 that prevents iron exit from cells [65-67]. Hepcidin binding to FPN1 also 
transduces regulatory signals in macrophages that suppress pro-inflammatory secretions 
[68]. Liver hepcidin secretion is finely tuned by various sensors of body iron, which 
include TfR2 and Human hemochromatosis protein (HFE), neogenin, hemojuvelin (HJV) 
and Bone Morphogenetic Proteins (BMPs) or the growth differentiation factor 15 
(GDF15).  TfR2, a low affinity receptor, senses Tf saturation (apo/diferric Tf) and 
depends on the MHC Cl I-like molecule HFE to activate hepatocytes’ secretion of 
hepcidin [69].  The bone morphogenic protein BMP6 also contributes to sense systemic 
iron levels; its binding to hepatocyte BMP receptors is regulated by neogenin and HJV 
and can lead to mothers against decapentaplegic homolog (SMAD)-dependent activation 
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of hepcidin antimicrobial peptide (HAMP) gene [70]. In contrast, hepcidin expression is 
down-regulated by elevated serum levels of GDF15, a member of the transforming 
growth factor beta (TGF-β) superfamily secreted by erythroid precursors from 
thalassemia patients [71]. 
Hepcidin secretion is also regulated in coordination with host immune response to 
infection.  This is not surprising given that this amphipatic peptide is a member of the 
defensin family of antimicrobial peptides [72].  Host response to infection stimulates the 
release of hepcidin together with inflammatory cytokines both from hepatocytes and M1 
macrophages [46, 47], forming a complex iron immunity network (Fig. 1).  Hepcidin 
secreted by M1 macrophages works in an autocrine fashion to down-regulate FPN1 and 
ensure iron retention in macrophages [73, 74]; hepcidin localized inside mycobacteria-
containing phagosomes showed anti-microbial activity [75]. Circulating IL-6 further 
stimulates hepcidin expression and release by hepatocytes [76]. In addition to blocking 
cellular iron efflux, hepcidin also impairs the expression of DMT1 and Dcytb in 
enterocytes and limits dietary iron uptake [77, 78]. Pro-inflammatory cytokines such as 
IL-1, TNF-α and IL-6 also upregulate ferritin expression and down-regulate TfR 
expression in the reticuloendothelial system.  IFN-γ and TNF-α also increase NRAMP1 
and DMT1 expression [79, 80] and contribute to iron sequestration in M1 macrophages. 
Increased iron retention in cells causes hypoferremia and eventually sabotages 
erythropoiesis by handicap of hemoglobin synthesis, a phenomenon alternatively termed 
anemia of chronic disease or anemia of inflammation [81].  
In contrast, anti-inflammatory cytokines, such as IL-4, IL-10 and IL-13 induce the 
expression of CD163 by M2 macrophages for uptake of hemoglobin/haptoglobin 
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complex [82] as well as necessary molecular functions to maintain iron flux and 
homeostasis (e.g., Tf, TfR1, HFE, STEAP3, DMT1, FPN1, IRPs, [46, 47]. Thus, 
hepatocytes and macrophages are key cells for maintenance of iron homeostasis which 
perform distinct functions depending on the physiological context, indicating either 







Fig. 1.  Mammalian iron metabolism is regulated by innate immunity. 
A. Iron homeostasis in erythroid precursors. Bone marrow precursors that generate RBC 
acquire iron mostly via the Tf-TfR pathway. The highly-expressed Steap3 reduces ferric 
iron to ferrous iron. DMT1 transports divalent iron out of the endosomes for downstream 
usage, mostly heme synthesis in mitochondrion. As a protection against heme overload, 
surface FLVCR can transport excess heme out of erythroid precursors.  
B. Iron homeostasis in Enterocytes. Enterocytes mediate dietary iron uptake to upload Tf 
in the circulation. Ferric iron in the proximal intestinal lumen is first reduced to ferrous 
iron by the iron reductase Dcytb, and is then transported into enterocytes by DMT1. 
Heme uptake by surface receptor HCP1 is a backup system for iron acquirement under 
conditions of iron depletion.  
C. Liver constitutes the headquarters for iron metabolism regulation. Most molecules 
involved in iron metabolism are synthesized in hepatocytes which can acquire iron 
through multiple pathways. In addition, hepatocytes release hepcidin, the peptide 
hormone that regulates iron metabolism systemically. 
D. Macrophages serve as an iron recycling factory in resting conditions. Senescent RBCs 
and apoptotic cells are engulfed and degraded by macrophages which become polarized 
towards M2 phenotype for efficient iron recycling. Iron is released after the heme 
molecules are oxidized by HO and NRAMP1 may promote iron recycling from the 
phagosome. Besides, M2 macrophages can also scavenge hemoglobin directly by the 
surface receptor CD163, and acquire other iron-containing molecules, including Tf, Lf 
(refer to the text for details). M2 macrophages release iron through the exporter FPN1. 
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Upon detection of pathogen-associated molecular patterns, macrophages up-regulate M1 
functions and secrete hepcidin locally. Hepcidin, together with the inflammatory 
cytokines released during the immune response form a complex iron immunity network 
that coordinates host defenses against pathogens. The effects of stimuli that polarize 
macrophages towards a type 1 (e.g., PAMPs/LPS, IFNγ, TNFα, IL1 and IL6) or type 2 
(e.g., IL10 and IL4/13 cytokines) phenotypes are indicated in red and green colors 
respectively. Their impact on the functions of hepatocytes, enterocytes and erythroblasts. 
“+” or “-” represents up- or down-regulation respectively. Pro-inflammatory cytokines 
block body iron cycling by increasing intracellular retention, which reduces Tf saturation 
in the circulation; they also stimulate microbicidal functions of M1 macrophages. In case 
the immune response is inefficient, it will lead to tissue damage, hypoferremia and 
eventually anemia of chronic disease. In contrast, anti-inflammatory cytokines can 
reverse this trend by promoting iron circulation and tissue repair, and restoring iron and 




Iron acquisition by protozoan parasites 
As antagonists of host iron homeostasis, pathogens have developed an array of 
mechanisms to acquire iron and interfere with host regulation of iron metabolism, 
including carrier, uptake and storage functions. Iron acquisition in pathogens has long 
been recognized as an expression of virulence [83-85] and iron starvation constitutes a 
possible avenue for pathogen elimination [86, 87]. Our knowledge about bacterial [84, 88] 
and fungal [85, 89, 90] iron uptake pathways is better established than that of protozoan 
parasites. However, utilization of drugs targeting pathogen iron trafficking pathways as a 
treatment for parasite infection preceded that for bacteria [87]. Artemisinin extracted 
from plant Artemisia annua has been used as anti-malaria drugs in China since 17th 
century. The working mechanism of artemisinin has not been fully elucidated, but it is 
known to have multiple targets in the parasite Plasmodium falciparum [91]. It is 
generally accepted that iron, heme and ROS are important in the antimalarial activity of 
Artemisinin, possibly interrupting ferriheme storage, the final step in the unique P. 
falciparum iron trafficking pathway [87] by inducing rapid and dramatic iron-catalyzed 
ROS accumulation in plasmodia mitochondria [92]. Iron chelators, such as DFO, 
salicylaldehyde isonicotinoyl hydrazone (SIH) and deferiprone that actively kills malaria 
parasites in vitro were selected for further evaluation as a regimen or potential 
chemotherapeutic adjuvant treatment in human [93, 94].  
 As previously mentioned, host iron metabolism is closely regulated by cytokines 
to ensure that iron is sequestered away from pathogens detected by the host. Most, if not 
all, pathogens interfere with host innate immune system by modulating cytokine 
production, and potentially creating a micro-environment conducive for iron uptake. 
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Indeed, protozoan parasites are able to disturb host innate immune responses notably by 
“confusing” macrophages. A comparative study of macrophage response to the 
kinetoplastid parasites Leishmania spp. and Trypanosoma cruzi by Zhang and colleagues 
[95] indicated that L. mexicana infected macrophages show no significant transcriptional 
response. IL-12 is a key cytokine for the generation of protective immunity to L. major 
infection. It has been reported that IL-12 secreted by M1 macrophages (and/or mature 
dendritic cells) can activate NK cells and CD8+ T cells to drive the development of a Th1 
type immune response, including the production of IFN-α [96, 97]. However, L. major 
promastigotes are able to inhibit the macrophage release of IFN-α/β [98]. It seems that 
the major strategy used by Leishmania spp. is impeding the host Th1 immune response, 
while T. cruzi actually induces a delayed activation of IFN response [95, 99] that can be 
related to the parasite’s unique ability to escape from the parasitophorous vacuole (PV) to 
the cytosol. Moreover, the transcriptional profile of macrophages infected by T. cruzi is 
closer to the response of macrophages stimulated by cytokine IL-4, IL-10 and IL-17 than 
M1 macrophages [95]. Different from these two kinetoplastid parasites, Toxoplasma 
gondii is a strong inducer of cell-mediated immunity, and a large amount of 
proinflammatory cytokine is produced during in vivo infection. However, intracellular 
infection by T. gondii actively down-modulates host proinflammatory signaling pathways 
potentially by histone modification of inflammatory cytokine genes [100].  
It is probable that by interfering with host innate immunity, parasites are able to 
deregulate iron metabolism and ensure access to iron for their survival. It seems that 
protozoan parasites are able to obtain different forms of iron depending on their living 
environment. Protozoan parasites can usually be classified as extracellular or intracellular 
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pathogens, while some have complicated life cycles involving extracellular and 
intracellular stages. A summary of common protozoan parasites, their particular parasitic 
niches, and the iron-containing molecules in those niches is illustrated in table 1. For 
some parasites listed, however, there is no information available on iron acquisition 
pathways, and comparing information about the parasites living in a similar niche may 




Table 1. Common protozoan parasites and their parasitic niches in host 
Infected organ/ host cell types Iron containing moleculesa Protozoan parasite 
Gut/NA Transferrin, lactoferrin Giardia, Entamoeba,  Isospora, Balantidium  
GU tractb/NA Transferrin, lactoferrin Trichomonas, Trtrichomonas 
Bloodstream/ NA Transferrin, hemoglobin, lactoferrin Plasmodium, Trypanosoma, Leishmania promastigotes 
Liver/ NA Transferrin, lactoferrin, hemoglobin, ferritin Entamoeba 
CNSc/ NA Neuroglobin Naegleria 
Spleen, liver/ Macrophage Transferrin, ferritin, hemoglobin Leishmania amastigotes, Toxoplasma gondii 
Muscle/ Muscle cells Myoglobin Trypanosoma cruzi, T. gondii 
CNS/ Astrocyte Neuroglobin Trypanosoma, T. gondii 
 
a All the potential iron-containing molecules in the particular organs are listed. Only some of them were identified to be the iron 
source for protozoan parasites 
b Genitourinary tract 
c Central nerve system
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1. Iron acquisition by extracellular protozoan parasites 
One advantage for mammalian bloodstream parasites is that they reside in the 
largest iron reservoir. Around 70% of the total iron in the host exists in the form of 
hemoglobin [101]. In addition, 90% of iron recycling from RBCs depends on the 
endosomal transferrin cycle (Tf-TfR1-Steap3-Dmt1). As a tradeoff for easy access to iron 
though, bloodstream parasites are under the direct challenge of humoral immunity. T. 
brucei, the parasite causing African trypanosomiasis, stays and multiplies in mammalian 
bloodstream throughout the whole infection cycle, obtaining iron from host Tf and using 
surface antigenic variation as primary mechanism of immune evasion. In chronic 
trypanosomiasis, the parasite can also invade CNS. In contrast, Plasmodium sporozoites 
get into host bloodstream when infected insect vectors, Anopheles spp. are taking a blood 
meal. After their invasion into hepatocytes, Plasmodium sporozoites develop into 
merozoites that are released again into the circulation to invade RBCs. T. cruzi and 
Leishmania spp. have also complicated life cycles with intracellular and extracellular 
stages. They are both injected by insect vectors into host subcutaneous tissues and reach 
the host cells within which they multiply (muscle cells for T. cruzi and macrophages for 
Leishmania). Entamoeba histolytica is a strictly extracellular parasitic protozoan that 
infects humans and other primates. The non-infectious cysts enter the host via 
contaminated food and water, and undergo maturation and a unique excystation process, 
in which one single cyst is converted into eight trophozoites that migrate to the large 
intestine and invade the intestinal mucosa. As the infection develops, the parasites gain 




As early as 1994, Wilson and colleagues demonstrated the acquisition of iron 
from host transferrin and lactoferrin by Leishmania promastigotes, and at the same time, 
they ruled out the possibility of other iron uptake pathways, such as siderophore-
mediated iron chelation and cleavage of host iron-binding proteins [102].  In addition, it 
was shown that transferrin uptake is delayed relatively to the lactoferrin uptake. The 
potential explanation given by the authors was that the transferrin acquisition mechanism 
had to be up-regulated. This study also presented several possible mechanisms for 
transferrin and lactoferrin uptake. A membrane receptor for transferrin and/or lactoferrin 
may be involved in the uptake and the inhibition of uptake of lactoferrin or transferrin by 
each other, suggesting a common receptor or a convergent pathway for uptake, which 
would be difficult to reconcile with the lag in transferrin uptake. A second line of thought 
is that a reductase is involved in iron acquisition, a strategy that has been demonstrated in 
Cryptococcus neoformans [103], Saccharomyces cerevisiae [104], and Histoplasma 
capsulatum [105]. Those potential uptake pathways were tested in a subsequent paper by 
the same group. It was found that host lactoferrin and transferrin bind non-specifically to 
a 70kDa parasite protein (Fig. 2). On the other hand, iron uptake using transferrin and 
lactoferrin was inhibited by competing ferric reductase activity and enhanced in the 
presence of a reducing agent like DTT. Therefore, these authors proposed a model for 
promastigote uptake of iron, in which the reduction of extracellular iron is followed by 
the transport of ferrous iron through transporter(s). The transporter involved in this 
process was identified recently by Huynh and colleagues [106] in Leishmania. 
amazonensis and L. major.  This Leishmania iron transporter (LIT1) is a membrane 
protein extensively similar to the ferrous iron transporter from Arabidopsis thaliana IRT 
20 
 
(iron regulated transporter), a member of the ZIP (Zrt-, Irt-like proteins) family. In L. 
amazonensis, a GFP-tagged LIT construct is expressed at the plasma membrane and in a 
perinuclear compartment, likely a megasome.  
In contrast to lactoferrin and transferrin uptake, hemoglobin endocytosis by L. 
donovani promastigotes is mediated through a specific protein located in the flagellar 
pocket[107]. Hemoglobin uptake as an avenue for heme acquisition is secondly relevant 
since Leishmania lacks a complete heme biosynthesis pathway. Electron and immune-
fluorescence microscopy showed that uptake begins with the binding of hemoglobin in 
the flagellar pocket, and is followed by internalization in early-endosome-like 
compartments, and eventual dispersion through the whole parasite cell [108] (Fig. 2). 
Trypanosoma brucei 
For T. brucei, the major source of iron is host transferrin [109]. First, transferrin 
binds to the flagellar pocket via a hetero-dimeric glycosylphosphatidyl-inositol-anchored 
receptor encoded by the genes ESAG-6 and ESAG-7 which are expressed in mammalian 
hosts [109].  Both ESAG-6 and ESAG-7 are localized upstream of and are co-transcribed 
with the gene coding for the parasite variant surface glycoprotein (VSG) in poly-cistronic 
transcription units [109]. There are several distinct expression sites containing different 
copies of these genes that encode TbTfR subunits with quite distinct affinities for Tf. 
Two hypotheses have been proposed for the advantages of expressing transferrin 
receptors with different affinities. First, due to its complex life cycle, T. brucei may need 
a repertoire of high affinity transferrin receptors directed toward proteins from different 
hosts. At any particular time point, the T. brucei population in a host expresses transferrin 
receptors encoded by different expression sites, with one of these being active in the 
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majority of the population. Despite that the host immune system may kill a large portion 
of the parasite population; this is also the tactic for the parasites to “fool” the immune 
system for the selection of the next population to expand. The other theory is that the 
diversified TfR can ensure the efficient iron uptake during chronic infection when the 
host immune system generates anti-TbTfR antibodies. It is still under debate what benefit 
exactly the parasite gains from the multiple and various TfR genes [109-111]. After 
binding, Tf is internalized through clathrin-coated vesicles to the endocytic pathway for 
degradation in the parasitic lysosomes [24] (Fig. 2). One cysteine protease is essential for 
the digestion of Tf [112].  
Entamoeba histolytica 
Iron availability is critical for anti-oxidative activity in E. histolytica since the 
parasite has iron-type SOD [113], further, iron is an important factor in adherence and 
cytotoxicity of E. histolytica to CHO cell monolayers [114]. The effect of Lf on the 
amoeba depends on the host iron physiological and dietary conditions. Holo-lactoferrin 
can specifically bind to two membrane proteins, internalized by caveolin-like protein to 
endosomal/lysosomal pathway. It is noteworthy that apo-lactoferrin can be used 
synergistically with human milk IgA and lysozyme as an anti-amoeba drug. It was shown 
that apo-lactoferrin binds to amoebic phospholipids and cholesterol, which are released 
before lysis. The same microbicidal effect of apo-lactoferrin was demonstrated in Giardia 
lamblia infection [24].  
E. histolytica is an aggressive iron scavenger capable of acquiring iron from 
almost all host iron-containing molecules. The parasite can spread to multiple organs 
through the systemic circulation and produce enzymes to rupture host cells. It has been 
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revealed by electron microscopy that E. histolytica trophozoites can ingest both dead and 
live RBCs [115].  Surface proteins, such as haemolysins and phospholipases [116] can 
bind and lyse the membrane of RBCs so that released hemoglobin is internalized for 
degradation.  It seems that extracellular parasites, such as Leishmania promastigotes and 
E. histolytica have developed a repertoire of surface proteins to bind to host iron-
containing molecules. At least two surface proteins from E. histolytica can bind to Tf, 
and one of them might be homologous to human TfR1 since it can be recognized by anti-
human TfR1 monoclonal antibody. After binding, Tf is internalized through clathrin-
coated vesicles [117], similar to T. brucei Tf scavenger pathway. The more astonishing in 
E. histolytica iron mining strategy is that this parasite can lyse enzymatically the 
hepatocyte membrane and absorb iron directly from host ferritin, which contains 1000-
fold more iron than Hb. Ferritin molecules are first bound to the surface protein, followed 
by cleavage into fragments, and internalization via clathrin-coated vesicles to the 
lysosomes [24] (Fig. 2). 
Tritrichomonas and Trichomonas 
Like E. histolytica, Tritrichomonas spp. can produce adhesive molecules to 
increase adherence to vaginal epithelial cells [118, 119]. Iron uptake pathways of 
Tritrichomonas spp. show versatile iron utilization by mucosal parasites. In 
Tritrichomonas, the majority of iron is associated with ferridoxin [120] that plays a 
critical role in glycolysis. The lack of mitochondria makes glycolysis the only energy 
generating avenue for the parasite. In its unique organelle, the hydrogenosome, 
carbohydrate metabolism activity is closely correlated with iron availability [121]. 
Therefore, it is not surprising that Tritrichomonas can acquire iron from wide-range 
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molecules via multiple pathways. Iron from different kinds of siderophores [122] can be 
used by T. foetus through pinocytosis, and siderophore-associated iron is probably 
released in acidic vesicles in the parasites. Since T. foetus can parasitize both the bovine 
vagina and uterus, it has access to both Lf and Tf [123]. Lf is taken through the 
endocytosis [124] pathway via a specific-receptor [125], while, Tf is processed by non-
specific pathways similar to those discussed in Leishmania promastigotes. An acidic 
environment is built around the parasites to release iron from Tf, followed by reduction 
of ferric iron and transport of ferrous iron [85, 123]. The in vitro uptake of low-molecular 
weight iron complex occurs in the same manner as Tf acquisition in vivo [125] (Fig. 2).  
The causative agent of human trichomoniasis, Trichomonas vaginalis uses 
adhesins, such as AP51 and AP65, for double functions as both adhesive molecules and 
binding proteins to heme and hemoglobin [126]. There are interesting reports about 
IRE/IRP-like systems in T. vaginalis to regulate expression of virulence factors such as 
adhesion and cysteine proteinase that induce apoptosis of host cells[127, 128], consistent 
with the ancient origin of the IRE/IRP system in evolution. Further, a lactoferrin-specific 
binding protein has been reported [129]. Like E. histolytica, T. vaginalis can also 
specifically bind to RBC and alternatively use hemoglobin as the iron source [130]. 
Other extracellular protozoan parasites 
The iron uptake pathways indentified in extracellular protozoan parasites 
discussed above are illustrated in Fig. 2. However, our knowledge about iron acquisition 
pathways used by extracellular parasitic protozoans is still lacking for most species. 
Although it has been demonstrated that Giardia infection results in decreased iron level 
in patient serum[18], which is probably a outcome from hypoferremia due to the host 
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immune response to withhold iron, nothing is known about Giardia iron uptake. We 
don’t know how Naegleria fowleri  acquire iron from the host, while inhibition of the 
parasite by iron chelators was reported [131]. Iron-type mitochondrial SOD was 
identified in Cryptosporidium parvum [132] and based on a recent report, an ATP half-
transporter CpABC4 in the parasite was characterized as iron-sulfur cluster transporter 







Fig. 2. Summary of iron uptake pathways identified in extracellular protozoan 
parasites.  
Extracellular parasites are surrounded by high concentrations of host iron-associated 
molecules. Host Tf can be obtained by extracellular parasites following specific- and 
non-specific binding. Examples of specific-binding of Tf by parasite surface receptors are 
provided by Trypanosoma and Entamoeba. The system for non-specific binding and 
uptake of Tf is generally coupled with a ferric reductase and a ferrous iron transporter. 
This strategy is shared by Leishmania and Trichomonas. Host Lf can also be acquired via 
specific- and non-specific pathways. Leishmania expresses non-specific surface protein 
to capture Lf while Tritrichomonas owns Lf-specific receptors. In addition to Tf uptake 
pathways, Entamoeba can also acquire iron from hemoglobin and ferritin. Entamoeba has 
the ability to bind and rupture RBC, or even engulf the whole RBC. Entamoeba is also an 
example of iron acquisition from hepatocyte ferritin by secreting perforing enzymes that 
destroy the hepatocyte membrane and digesting the liberated ferritin. All receptor-
specific binding of host molecules are followed by internalization inside vesicles and 
degradation in lysosomes. Details can be found in text.
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Iron acquisition by intracellular protozoan parasites 
As compared to extracellular pathogen varieties, our knowledge about iron 
acquisition mechanisms in intracellular parasites, with the exception of Leishmania 
amoastigotes, is even more limited.  
Leishmania amastigotes 
The intracellular parasite lifestyle of Leishmania amastigotes comprises the same 
set of iron acquisition pathways as promastigotes [134] that is supplemented to facilitate 
iron delivery of through the physical and immune barriers inside host cells. Tf has been 
suggested to be the source of iron for L. amazonesis and L. pifanoi, because gold-labeled 
Tf was detected in the parasitophorous vacuole (PV) seven day post-infection [135]. This 
was unexpected since Tf is delivered through the early endosomal pathway while the PV 
is formed after late endosomal pathway. To explain the unusual appearance of Tf in the 
PV, evidence was presented in pulse-chase experiments that the macrophage endosomal 
pathway is subverted by Leishmania infection. Recently, it has been found that in 
addition to developing ways to acquire host iron from different sources, Leishmania 
parasites deplete the labile iron pool of Nramp1-/- macrophages [136]. As mentioned 
above, upon infection macrophages normally reduce their capacity for iron uptake and 
increase the expression of the iron storage protein ferritin.  But within 12 h after L. 
donovani infection, mouse TfR1 (mTfR1) was up-regulated; similar up-regulation was 
detected in macrophage treated with DFO. Increased mTfR1 expression was the result of 
enhanced mRNA stability via the augmented IRE/IRP  interaction [136]. Notably, though 
all the experiments by Das et al. (2009) were performed within 24 h after infection, and 
detection of Tf in PV was carried on day 7 after infection [135], re-routing of transferrin 
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was observed both at 60 min and 18h post-infection [136]. Combining those results, it 
may be inferred that depletion of the host cell labile iron pool can benefit the parasite 
during early stages of infection. Meanwhile, alteration of host endosomal trafficking 
pathway actually starts as early as the first hour of infection, which sets the stage for 
gaining iron later in the process as host cells are stimulated to replenish their iron pool.   
It remains unclear how the parasite actually depletes the host labile iron pool. Das 
and colleagues pointed out the possible role of Leishmania intracellular iron scavenging 
pathways and suggested that they may provide new drug targets. But macrophages used 
in these studies lacked a functional Nramp1, which artificially limited host cell capacity 
to counter-act Leishmania activity and expel iron from PV. Nevertheless, another 
interesting finding [137] is that a protein from L. tarentolae extracts can interact with 
mammalian IRE. An alternative possibility might thus be that Leishmania secrete a 
protein to perturb directly the host cell IRP/IRE regulatory network, “simulating” iron 
starvation to upregulate TfR1 and reduce ferritin expression. In any case LIT is another 
important player for iron acquisition by amastigotes. LIT expression is accelerated under 
iron depletion conditions, such as expression of host Nramp1, suggesting competition for 
iron between LIT and host Nramp. LIT knockout has no significant effect on 
differentiation of promastigotes into amastigotes, but it abolishes amastigote division and 
the parasite virulence, indicating that LIT has a critical role at the intracellular stage. 
Other intracellular protozoan parasites 
The exact iron acquisition pathway in malaria parasite Plasmodium spp. is still unknown 
though it is clear that malarial pathogenesis results in delocalization of systemic iron 
(Nweneka CV et al., 2009). In 1988, it was pointed out that if host Tf is one of the iron 
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sources for the parasites, it is not delivered via host TfR1 [138]. Detection of ferric 
transferrin reductase on the plasma membrane of infected RBCs and the expression of 
parasite-derived TfR in RBC membrane indicated a possible transferrin-dependent iron 
uptake [139]. Radioactive-labeled transferrin failed to enter the parasites; however, 
radioactive-labeled low molecular-weight iron-complex can reach both uninfected, 
infected RBC and the parasites, suggesting a transferrin-independent iron uptake pathway 
[140]. It would be very surprising that Plasmodium embedded in a huge hemoglobin pool 
cannot exploit this easy iron source. It is known that inhibition of heme synthesis can 
impair hepatic development of P. yoelii [141]. The HOs that catalyze iron release from 
heme molecules were thought to be absent in the parasites until recently, when such 
activity was detected for a HO-like protein located in apicoplast [142]. Also, it seems 
worth noting that plasmodia genomes encode a predicted Nramp homolog,  
It is not clear either how T. gondii parasites gain access to host iron, although two 
Toxoplasma proteins from endocytic rhoptries were demonstrated to bind human 
lactoferrin [143]. Further information may be obtained from T. gondii intracellular 
parasitism of placental trophoblasts. The concomitant presence of pregnancy and 
intracellular infections for which host protection depends on Th1 response is well 
documented. Immunocompetent individuals resolve T. gondii infection by relying on 
secretions of IFNγ, IL1β and TNFα, but during pregnancy, anti-inflammatory cytokines 
such as IL-4, IL-10 and TGF-b dominate to maintain immunological tolerance, together 
with innate antimicrobials such as defensins [144]. Fetal growth depends on transfer from 
maternal blood of various nutrients and molecules, including diferric Tf, which proceeds 
across polarized epithelial cells by receptor-mediated transcytosis [145]. Trophoblasts are 
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frequently parasitized by T. gondii, and in vitro this infection can be controlled by 
neutralizing endogenous IL-10 and TGF-β and providing IFN-γ [146]. This suggests that 
this parasite hijacks a vulnerable iron pool within trophoblasts. Besides, T. gondii [147] 
and Trypanosoma cruzi [148, 149] can invade muscle cells and CNS, and it was 
hypothesized that host myoglobin and neuroglobin could protect the parasites from 
nitrosative stress. The above reports imply that the parasites have access to the particular 











Fig. 3. Summary of iron uptake pathways identified in Leishmania amastigotes.  
For intracellular parasites (e.g. the Leishmania spp. amastigote stage), new challenges 
arise from the host’s physical and immune barriers that defend iron store against potential 
pathogens. The blue arrows indicate the pathways in uninfected or M2 host macrophages, 
and the red arrows represent steps following the parasite entry. In uninfected host cells, 
transferrin receptors bind circulating transferrins and are endocytosed. In addition, M2 
macrophages phagocytose effete cells and recycle their internal iron. Following 
acidification of endosomes/phagosomes, ferric iron is released and converted to ferrous 
iron by Steap3, before being translocated by Nramp2/Dmt1into the host cytoplasmic LIP, 
together with iron extracted from heme. Because M2 macrophages express FPN1, the 
majority of cytoplasmic ferrous iron is exported, oxidized by ceruleoplasmin and then 
loaded onto Tf while the excess is stored in ferritin in the ferric form. Leishmania 
amastigotes may be able to deplete host cell LIP by mimicking iron starvation that would 
ultimately down-regulate host ferritin while up-regulating transferrin receptor expression 
(indicated by red arrows). Increased trafficking of diferric transferrin into the endocytic 
pathway would facilitate parasite-driven delivery of host iron to PV. As part of host iron 
recycling machinery and macrophage defense system, Nramp1 is recruited to the 
membrane of late endosomes/lysosomes and PV to withdraw iron from these 
compartments. However, parasitic LIT may compete with Nramp1 to secure iron import 






Identification of Nramp as a marker for resistance to infection  
Nramp1 (natural resistance-associated macrophage protein 1) was identified from 
a survey of inbred mouse strains in a model of Salmonella typhimurium infection. Results 
showed that resistant (LD100>104-105 bacteria) or susceptible (LD100<100 bacteria) 
phenotypes to Salmonella infection were controlled by a single locus (Ity) [150]. 
Similarly, another group showed independently that the replication of Leishmania 
donovani in mouse tissues was either allelic or tightly linked to Lsh [151]. More recently, 
a third locus (Bcg) was mapped to the same region of mouse chromosome 1 (Bcg/Lsh/Ity 
locus) [152] in in vivo studies of mycobacteria replication [151-154]. In each case the 
resistant allele that permitted restriction of intracellular replication of the infectious 
agents was shown to be dominant. By positional cloning the chromosomal region 
covering the Bcg/Lsh/Ity locus was found to encode six candidate genes, and was 
expressed exclusively in macrophages extracted from spleen and liver [152]. The highly 
hydrophobic integral trans-membrane protein encoded by this mRNA was reminiscent of 
a transporter or an ion channel. Later studies rigorously demonstrated that Nramp1 
(Bcg/Lsh/Ity gene or Slc11, Solute carrier 11) was involved in host resistance to 
intracellular infections. Interestingly, it was a single Gly169Asp substitution in predicted 
TMS4 of the protein that was responsible for the susceptibility trait. These findings 
spiked the search for Nramp in humans where it was also shown to be associated with 
resistance to infection with a variety of intracellular pathogens. This studies revealed that 
Nramp as a promising marker for resistance to intracellular pathogens. Prompted by this 
possibility, strong interest was generated in searching for this marker in agriculturally 
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important animal species such as of chickens and cattle, to increase the overall level of 
genetic resistance by using selective breeding programs [155-157]. Pursuing the same 
objectives, the Nramp gene has also been described in numerous wild and farmed fishes 
[158-163]. 
Nramp functions in metal homeostasis  
Functional studies revealed that Nramp homologs are proton-dependent divalent 
metal transporter with a high affinity for Mn2+ and Fe2+. Heterologous expression studies 
of Nramp family members from various organisms have identified several metal 
substrates, including Cd2+, Cu2+, Co2+ [164-166],  and even Ca2+ [167]. Besides the 
mammalian Nramp1, the Nramp isotype, Nramp2, or DMT1 was identified and 
characterized [168]. A mutation (G185R) at the Nramp2 locus causes microcytic anemia 
and iron deficiency in the mk mouse and the Belgrade rat [169, 170], a pathology 
associated with decreased iron uptake in the duodenum, and impaired iron metabolism in 
peripheral tissues. Nramp2 is believed to function as the major transferrin-independent 
iron uptake system at the intestinal brush border, and in the transport of transferrin iron 
across the membrane of acidified endosomes as part of transferrin cycle [171]. 
Nramp homologs are ubiquitously present in virtually all taxa. In yeast, the 
Nramp homologs SMF1 and SMF2 transport Mn2+, but also Cd2+, Cu2+ and Co2+ at lower 
rate, while SMF3 is presumed to mostly transport Fe2+ [166]. The fruit fly Nramp 
homologue, malvolio, is expressed primarily in the brain, and mutations at this locus 
cause a sensory-neuron defect in taste discrimination. The mutant phenotype can be 
corrected by dietary Fe2+ or Mn2+, and by expression of mammalian Nramp1 in malvolio 
transgenic flies [172]. The plant Nramp family has been well documented in both 
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genomic and EST databases, demonstrating that genes from this family are present in 
virtually all plants studied at the molecular level. Functionally, plant Nramp genes 
complement yeast mutants deficient in the uptake of several metals, including Fe2+, Mn2+, 
and Zn2+, suggesting that their function as metal transporters is conserved across various 
taxa. Schistosoma mansoni, an intravascular human parasite with a high nutritional and 
metabolic demand for iron, has two Nramp homologues (SmDMT1A and SmDMT1B) 
with different expression patterns and subcellular compartmentalization. SmDMT1 
localizes primarily to the tegument, suggesting that the parasite uses this transporter for 
iron acquisition [173]. 
Nramp as a potential microbial virulence factor 
As mentioned above, iron, and possibly other divalent cations are necessary for 
the growth of microbial pathogens and parasites; therefore, their metal transporters have 
been investigated as candidate virulence factors. Manganese was recognized as necessary 
for virulence in certain bacteria, and one of the reasons is that some bacteria use 
manganese as their SOD cofactor [174].  The bacterial Nramp homologs MntH (H+-
dependent Mn transporter) are widespread. Disruption of MntH in Escherichia coli and S. 
typhimurium does not affect bacterial growth under aerobic conditions in minimal or rich 
medium, implying that MntH is not essential for growth under normal laboratory 
conditions [175, 176], and at least one potentially redundant manganese acquisition 
system (e.g. ATP-binding cassette transporter) is present in pathogenic enterobacterial 
microorganisms [177]. The lack of a strong growth phenotype suggests either that Mn2+ 
is not critical for growth or that other enterobacterial transporters can compensate for the 
loss of MntH-mediated uptake. However, elimination of the Gram positive Bacillus 
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subtilis mntH gene prevented bacterial growth in Mn-limited medium, implying that 
bacterial physiology influences mntH phenotype [177]. It was demonstrated in E. coli 
that overexpression of mntH from a plasmid could restore growth of the temperature 
sensitive hflB1 mutant, which requires high intracellular metal concentrations to grow at 
non-permissive temperatures [177]. In addition, when MntH was overexpressed, E. coli 
cells become more sensitive to Mn2+, Cd2+, Co2+, Fe2+, Ni2+, and Cu2+ and direct 
measurements of radio-label uptake showed that E. coli MntH has higher affinity for 
Mn2+ [176]. Likewise, it was confirmed that overexpression of mntH renders both E. coli 
and S. typhimurium more sensitive to growth inhibition by Mn2+ and Cd2+, and that the 
loss of mntH rendered them more sensitive to hydrogen peroxide but not to superoxide. 
Although bacterial pathogens acquire host iron and other divalent metals via multiple 
routes, Nramp homologs (MntH) identified in M. tuberculosis [178], M. leprae [179], and 
Salmonella spp. [175] represent potential virulence factors.                                                                          
A “tug-of-war” for iron through host and pathogen Nramp homologs  
The concept of "nutritional immunity" defines the dynamic interaction between 
pathogens and hosts, including the competition for essential nutrients such as small 
organic molecules, amino acid, fatty acids, nucleotides and other co-factors [22]. Hence, 
the innate resistance to infection by intracellular pathogens is, at least in part, derived 
from basal metabolic functions, and influenced by genetic factors [21]. An instructive 
example for nutritive host–pathogen competition is represented by the mutual 
requirement for iron, manganese, and potentially other divalent cations. One illustrative 
example is the divalent cation transporter Nramp, which plays roles in both trace metal 
acquisition and natural defense against intracellular pathogens.  
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Two different theories have been proposed about how the host Nramp1 functions 
in defense against intracellular pathogens. One theory implies that Nramp1 might 
increase intraphagosomal Fe2+, and through the Haber-Weiss/Fenton reaction facilitates 
the generation of microbicidal reactive oxygen species [180, 181]. The second suggests 
that Nramp1 deprives the intraphagosomal pathogen of Fe2+ and other divalent cations 
critical for growth and for the pathogen’s effective antioxidant defense [182-184]. 
Accumulating evidence further supports the prime role of Nramp as a first line defense 
that limits essential metal availability to intracellular pathogens, not only in animal hosts 
but also in amoeba and plants [185]. In M. tuberculosis, it has been suggested that the 
prokaryotic Nramp homolog (MntH) might be in direct competition with the host Nramp 
for iron and other divalent cations [178]. A proposed “tug-of-war” for iron between 
oyster and P. marinus Nramp is illustrated in Fig. 4, in which the host Nramp1 mediates 
efflux of divalent cations (including Fe2+ and Mn2+) from inside the phagosome and into 
the cytoplasm. Acidification of the phagosomal space by vacuolar H+/ATPase would 
provide the proton gradient as the driving force for metal efflux. Deprivation of Mn2+ and 
Fe2+ could deplete the parasite of nutritional metals, prevent success of individual 
survival strategies (virulence factors), and/or disable the pathogen-encoded detoxifying 
enzymes (SOD, APX, among others). The microbial archetype Nramp homologs likely 
function by a similar mechanism, both for the acquisition of metals from the environment, 
and in the competition for the same substrate(s) with their host counterpart(s). This 
question was raised whether there is a “tug-of-war” for iron between oyster hemocytes 
and intracellular P. marinus. As mentioned before, iron is critical for P. marinus growth 
and prevalence of infection, but no iron uptake pathway has been identified. Exploring 
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Nramp homologs in P. marinus and the functional characterization of the homolog(s) 
may not only provide a novel avenue for disease intervention, but also shed some light on 
the Nramp-involved iron metabolism in other intracellular protozoan parasites. 
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CHAPTER 2 MOLECULAR CHARACTERIZATION 
OF TWO NOVEL NATURAL RESISTANCE-ASSOCIATED 
MACROPHAGE PROTEIN ISOTYPES (PMNRAMP2 AND 
PMNRAMP3) IN PERKINSUS MARINUS 
SUMMARY 
Perkinsus marinus, a pathogenic intracellular protozoan parasite of the eastern 
oyster, Crassostrea virginica, requires iron for proliferation and virulence. In a previous 
study, a divalent metal transporter (PmNramp1) was described as a potential iron 
transporter in the parasite. In this chapter, two extra P. marinus Nramp homologs 
designated PmNramp2 and PmNramp3 are described. Among the three PmNramp 
isotypes, PmNramp2 was similar to PmNramp1 in the aspects of amino acid sequence 
and exon-intron boundaries. Nucleotide and amino acid sequences analyses indicate that 
PmNramp2 and PmNramp3 encode predicted membrane proteins of 649 and 559 amino 
acids respectively. Topology prediction software programs suggest 10 to 12 TMS in both 
PmNramp2 and PmNramp3. Regular RT-PCR was performed to detect the transcript of 
the three PmNramp isotypes, and indeed, the three Nramp isotypes are transcribed in 
cultured P. marinus trophozoites. All the PmNramp isotopes have a SL at the 5’ ends. 
The sequence of the SL is highly similar to dinoflagellate SL. Further examination 
proved the presence of the SL in other genes of the parasite. P. marinus heat shock 
proteins (PmHSP70 and PmHSP90) and antioxidant gens, including superoxide 
dismutases (PmSOD1 and PmSOD2) and ascobate peroxidases (PmAPX1 and PmAPX2) 
are trans-spliced. Iron overload, iron depletion and host serum challenge did not change 
the transcript level of PmNramp isotypes and tested antioxidant genes as accessed by 
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quantitative PCR (Q-PCR). Temperature change did not have a significant impact in 
PmHSP transcription. The identification of SL and the lack of change in transcription 
suggest a constitutive polycistronic transcription in P. marinus. 
INTRODUCTION 
Once inside the oyster hemocyte, P. marinus must acquire from the host trace 
elements, such as iron, which are essential for pathogen survival. A putative divalent 
cation membrane transporter that may be responsible for iron uptake is previously 
identified in P. marinus (hereafter designated as PmNramp1) [186], which is the first 
report about Nramp homologs in alveolates. The cDNA sequence of PmNramp1 was 
obtained and sequenced. PmNramp1 cDNA turns out to be 2,082 base-pair (bp) long with 
a CDS for 518 amino acids. Topology prediction implies that PmNramp1 is an integral 
membrane protein with 12 TMS. Southern blot analysis indicates PmNramp1 exists as a 
single copy gene in P. marinus strain TXsc (ATCC number 50849) [186]. 
In mammals, two different Nramp isotypes are characterized [162, 168, 169, 187]. 
While baker yeasts, Saccharomyces cerevisiae, has three Nramp homologs [188, 189]. P. 
marinus genome database provides a powerful tool for searching genes of interest. As a 
continuous study of the identification of PmNramp1, the possibility of other Nramp 
isotypes in P. marinus was explored since Nramp can exist as several different forms in 
an organism. In this chapter, two new PmNramp isotypes were described in the aspects of 
gene organization and transcription regulation.  
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MATERIALS AND METHODS 
Perkinsus marinus cultures 
The Perkinsus marinus strain CB5D4 (ATCC# PRA-240) [190] was propagated 
in Perkinsus standard culture medium [Dulbecco modified Eagle's (DME): Ham's F12 
(1:2) with 5% fetal bovine serum (FBS)] at 28 °C [191]. The details about the culture 
medium composition are listed in table 2. 
Genome mining 
cDNA and amino acid sequences of P. marinus Nramp (PmNramp1) [186] were 
used as query in the search of potential homologs in the P. marinus genomic database 
(http://blast.jcvi.org/er-blast/index.cgi?project=pmg). Two contigs were identified in the 
TIGR database using BLASTn, or tBLASTn programs in the BLOSUM62 matrix, 
respectively. The consensus sequences of the contigs were then used in NCBI BLASTx 
program (www.ncbi.nlm.nih.gov) to confirm their identity as Nramp homologs. 
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Table 2. The composition of Perkinsus marinus culture medium  
Chemical name Final concentration 
Dulbecco' modified Eagle's medium (DMEM) (Sigma Aldrich, St. Louis, MO) 5 mg/ml 
Ham's F12 nutrients mixture (HAM’s F12) (Sigma Aldrich, St. Louis, MO) 10 mg/ml 
artificial seawater (Instant Ocean, Mentor, OH) 15 mg/ml 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
(HEPES) 50 mM 
sodium bicarbonate 3.6 mM 
penicillin G 100 U/ml 
streptomycin sulfate 100 U/ml 
fetal bovine serum (FBS) 5% 
* Adjust pH to 6.6 
Nucleic acid extraction and cDNA cloning and sequencing 
Parasite cultures in log phase were harvested by centrifugation for 10 min at 500 g 
and the pellets were used for either total RNA extraction with the RNeasy Mini Kit 
(Qiagen, Valencia, CA) or DNA extraction with the QIAamp tissue kit (Qiagen) 
following the manufacturer’s instructions.  
Table 3. Primers used for amplifying Perkinsus Nramp genes 
Primer Primer sequence PCR reaction 
PmNR1f 5’-TCT TCG CTG TTG GCA TAT TG-3’ RT-PCR of PmNramp1 PmNR1r 5’-TCT ATG GAA GCA GCA CAT CG-3’ 
PmNR2f 5'-CGC TAG GCT CGG TTT TGT AA-3' RT-PCR of PmNramp2 PmNR2r 5'-ATG CAT TGA TGC CGT TCA TA-3' 
PmNR3f 5'-CGC TAG GCT CGG TTT TGT AA-3' RT-PCR of PmNramp3 PmNR3r 5'-CAC TGC GGA ACC CAA TAC TT-3' 
PmNR2fullcDNAf 5'-ATT ATT ATG TCT ATT GTC GC-3' Amplification of PmNramp2 full cDNA 




One microgram of P. marinus RNA was transcribed into cDNA using GeneRacer 
Core Kit (Invitrogen, San Diego, CA) according to the manufacturer’s protocol; another 
microgram of total RNA was used to generate first-strand cDNA as reported elsewhere 
[192]. Based on the partial sequences of the PmNramp homologues obtained from 
genome mining, gene specific primers (PmNR2f, PmNR2r, PmNR3f, and PmNR3r, 
Table 2) were designed using the web-based software Primer3 (http://frodo.wi.mit.edu/) 
for RT-PCR. The 5’ and 3’ ends were subsequently obtained by rapid amplification of 
cDNA ends (RACE) with the GeneRacer kit (Invitrogen). For 3’ RACE, the method 
described by Borson was also used [192]. The 5’ and 3’ RACE products were cloned into 
the pGEM-T vector (Promega, Madison, Wisconsin), and sequenced (3120X/Genetic 
Analyzer, Applied Biosystems, Carlsbad, California). Finally, to confirm the full-length 
PmNramp2 and PmNramp3 cDNA sequences, primers were designed to target the 
predicted 5’ UTR (Table 2) to amplify the full cDNA by 3’ RACE. Products were cloned 
and sequenced as above. All PCR reactions were performed using High Fidelity Taq 
DNA polymerase (Takara, Otsu, Shiga, Japan), with the following settings: 94°C /5min, 
35 cycles of 94°C/1 min per kbp, 50-60°C/30sec, and 72°C/2-4min. 
Identification of trans-splicing leader in other genes 
In order to test if other genes in P. marinus are trans-spliced, a forward primer 
was designed based on the 22 nucleotide sequence (SL forward, Table 4) and reverse 
primers were designed based on the cDNA sequenced of P. marinus SOD1, SOD2, 
APX1, APX2 cDNA sequences [14, 15]. Reverse primers were also designed based on 
partial cDNA sequences of two potential heat shock proteins, HSP70 (Accession # 
XM_002774278) and HSP90 (Accession # AY391259) identified in P. marinus genome 
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database (Table 4). RT-PCR using P. marinus cDNA as template was performed. PCR 
product was purified and sequenced to verify that the targeted anti-oxidant genes are 
actually amplified. 
Table 4. Primers used in testing of trans-splicing leader in other genes 
Primer Primer sequence 
SL forward 5’-TCC GTA GCC ATC TTG GCT CAA G-3’ 
SOD1reverse 5’-CAG CAG CGA TGC TAT TCA AA-3’ 
SOD2 reverse 5'-GCC TTT CGC ATG AAG TTC TC-3' 
APX1 reverse 5'-CGA TAC CCT CCT TTC CAT CA-3' 
APX2 reverse 5'-CCT CGC TAC CGT TGG TGT AT-3' 
HSP70 reverse 5’- GTTGCTCTTGCCAGTGGACTTA-3’ 
HSP90 reverse 5’- CAACACGGACCTTGTCAGCA-3’ 
 
Challenge experiment design 
Perkinsus marinus cells were grown as described above to log phase (optical 
density at 600 nm = 1.2).  Cells were pelleted by centrifugation at 1000 g for 5 min, 
washed with culture  medium (DME-HAM based) to remove FBS and inoculated into 
culture mediums including fetuin (1.7 mg/ml) as iron supplement to a final cell number 
around 8 Х 106 cell/ml (optical density at 600 nm = 0.64).  
Cation overload and depletion conditions were set up in DME-HAM base 
medium with fetuin as follows:  iron overload: FeCl2 (Sigma) stock solution (25 μg/ml) 
was added to the medium to reach the final concentration of 100 and 400 μM.  
manganese overload: MnCl2 (Sigma) stock solution (1M) was added to the medium to 
reach the final concentration of 0.3 and 0.8 μM.  iron depletion: DFO (Sigma) stock 
solution (20 mg/ml in P. marinus culture medium) was added to the culture medium to 
the final concentration of 0.01 and 0.08 mg/ml. To study the effect of host factor on the 
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expression of PmNramp isotypes, over one hundred oysters were ordered from Mook Sea 
Farm, Inc. (Walpole, ME).  All the oysters were notched and hemolymph was withdrawn 
from the adductor muscle with a 22 G needle and 3 ml syringe and collected in 1.5 ml 
eppendorf tubes on ice. A piece of oyster tissue was dissected from every oyster for DNA 
extraction using DNeasy Blood&Tissue Kit (Qiagen) followed by infection check via 
PCR-based assay [193]. Due to a high infection rate, a limited amount of uninfected 
oyster sera was available and the final concentration of oyster serum in the culture 
medium was 5%. All the culture medium was filter sterilized with 0.2 μm VacuCap 90 
(Gelman Sciences, Port Washington, NY) after preparation. To test the transcription 
regulation of PmHSP70 and PmHSP90, P. marinus culture was grown to log-phase 
(OD=0.6) and split to three groups: one stayed in optimal 28°C, one was put in 4°C and 
the other one in 37°C for 2 hs.   
All the challenge experiments were carried out in duplicates. During the time of 
experiment, parasite cells were incubated in 75 ml cell culture flask (Corning, Corning, 
NY) under 28°C. 0.5 ml culture was withdrawn for OD measurement using UV-1601 
UV-visible spectrophotometer (Shimadzu, Columbia, MD ) at different time points (at 
t=0, 18 hours, 2 days, 4 days, 7 days and 9 days). Meanwhile, 7.5 ml culture was taken 
from each flask for RNA extraction and eventually Q-PCR. 
RNA extraction and reverse transcription 
P. marinus cells were pelleted by centrifugation at 1000 g for 5 min. QIAshredder 
(QIAGEN) was used to homogenize the cells. RNeasy Mini Kit (QIAGEN) was used for 
RNA extraction from all the samples. Elimination of DNA contamination was achieved 
by using the RNase-Free DNase Set (QIAGEN). The final concentration of RNA from 
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each sample was measured by NanoDrop ND-1000 spectrophotometer (NanoDrop 
Products, Wilmington, DE). One microgram of RNA was used for the synthesis of the 
first-strand cDNA using RevertAid™ First Strand cDNA Synthesis Kit (Fermentas, 
Ontario, Canada). 
Quantitative PCR 
The primers used in QPCR were designed using the free primer design tool 
OligoPerfect™ Designer from Invitrogen 
(http://tools.invitrogen.com/content.cfm?pageid=9716). All the primers sets (Table 5) 
used in QPCR were confirmed to have application efficiency from 90% to 110%. All the 
genes that are known to be trans-spliced, including the three PmNramp isotypes, PmSOD 
isotypes and PmAPX isotypes were tested for transcriptional change. Partial cDNA 
sequences of P. marinus 18S gene (Accession number ti:1520534126), heat shock protein 
were obtained from P. marinus genome database 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi?PROGRAM=blastn&BLAST_SPEC=TraceArchi
ve&BLAST_PROGRAMS=megaBlast&PAGE_TYPE=BlastSearch) was also included 
in the QPCR. All QPCR reactions were performed using Sybr Green PCR master mix 
(Applied Biosystems) in 7500 Fast Real-Time PCR system (Applied Biosystems), with 










Table 5 Primers used in quantitative PCR 
Target 
gene Forward primer Reverse primer 
Pm18S 5’-GCATTTGCCAAGGATGTTTT-3’ 5’-AAATTAACGACCCCCAATCC-3’ 
PmNramp1 5’- TTTGCTGCACGGTATCAGAG-3’ 5’- GGCATAATAACTGCGCCAAT-3’ 
PmNramp2 5’- GGCATTCACAGGTTTCCAGT-3’ 5’- CCTCTACGGCAATTCTCTGC-3’ 
PmNramp3 5’- CAGCCGCTGATACTTTCACA-3’ 5’- GAAGCAAGCGCACATTATCA-3’ 
PmSOD1 5’- CTGGCAAGCCTTTTAACCAG-3’ 5’- CGCTGAACTCCTCCTTGAAC-3’ 
PmSOD2 5’- GGGGAGAATGTGTTCAATGC-3’ 5’- GCCTTTCGCATGAAGTTCTC-3’ 
PmAPX1 5’- GCCTTCAAAGATCGTTCTGG-3’ 5’- CGATACCCTCCTTTCCATCA-3’ 
PmAPX2 5’- GGGCTTCAATGATCAGGAGA-3’ 5’- CCTCGCTACCGTTGGTGTAT-3’ 
PmHSP70 5’- GATAACCAGCCTGGTGTGTTGA-3’ 5’- GTTGCTCTTGCCAGTGGACTTA-3’ 




Identification of two novel PmNramp isotypes 
Genome mining of PmNramp homologs was performed with bi-direction BLAST. 
Both PmNramp1 cDNA and amino acid sequences were used as queries in BLASTn and 
tBLASTn programs respectively in the P. marinus genomic databases 
(http://blast.jcvi.org/er-blast/index.cgi?project=pmg, previous TIGR Perkinsus marinus 
Sequence Database).  Two contigs were returned as hits. One contig (No. 21203) came 
out as hit when PmNramp1 cDNA sequence was used as query; another different contig 
(No. 22669) was shown as hit when PmNramp1 amino acid sequence was used as query. 
The consensus sequences from the two contigs were then used as queries in NCBI 
BLASTx program (http://blast.ncbi.nlm.nih.gov/Blast.cgi) and both of them turned out to 
be Nramp homologs. Gene specific primers were designed based on the consensus 
sequences and used in regular RT-PCR. As shown in Fig.4, all the three PmNramp 
isotypes cDNA was amplified by those primers, indicating that all the three PmNramp are 
transcribed in the parasite trophozoites cultured in standard medium. 
The full cDNA sequences of the two new Nramp genes, hereafter designated 
PmNramp2 (GenBank accession No. EU589239) and PmNramp3 (GenBank accession 
No. EU836690) were obtained. The first in-frame initiator methionine codon of CDS is 
located at position 37 of the PmNramp2 cDNA sequence. PmNramp2 CDS was 1,947-bp 
long, encoding a putative protein of 649 amino acid residues with a predicted molecular 
mass of 70.5 kDa. The PmNramp3 cDNA was 1,726-bp long with a 1,677 bp CDS. The 
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putative PmNramp3 protein has 559 amino acids and is predicted to be 60.0 kDa. No 








Fig. 4. RT-PCR analysis of PmNramp isotypes in P. marinus trophozoites. 
cDNA of P. marinus trophozoites was used as template in regular RT-PCR. Gene-
specific primers used in the RT-PCR are listed in Table 3. cDNA: P. marinus cDNA; 
gDNA: P. marinus genomic DNA; N: water as negative control; M: 100-1.5kb DNA 
marker.1.2% agarose gel, ethidium bromide, 1X tris-acetate-EDTA.  
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Gene organization of PmNramp isotypes 
Gene structures were compared between the three PmNramp isotypes. Exon-
intron boundaries were obtained by alignment of sequences of genomic DNA and cDNA 
from the three PmNramp isotypes using the commercially-available software Sequencher 
4.2.2 (Gene Codes Corporation, Ann Arbor, MI). A side-by-side comparison of gene 
organization of the three PmNramp isotypes was shown in Fig. 2. PmNramp2 has 7 exons 
interrupted by 6 introns. Most of the exon/intron boundaries were characterized by the 
canonical splicing signal (GT/AG) with the exception of GT/GC non-canonical splicing 
signal in PmNramp2 intron 3. The translational start codon was within the exon 1 and the 
termination codon (TGA) was located in exon 7, which has a 3’ UTR more than 1 kb-
long. PmNramp3 has 14 exons interrupted by 13 introns and the start and stop codons 
were located in the first and the last exons, respectively. The exon/intron organization of 
PmNramp2 is similar to PmNramp1, which contained 8 exons, instead of the 7 exons 





Fig. 5. Gene organization of PmNramp homologs.  
Comparison of cDNA and gDNA sequences revealed exon-intron structures of the three 
PmNramp isotypes. Exons and introns are indicated by filled or open boxes, respectively 
The x-axis indicates size in bp. 
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Amino acid alignment of PmNramp isotypes with human Nramp2 homolog 
A pairwise amino acid sequence alignment (Fig. 6) of PmNramp2 and PmNramp3 
with human Nramp2 (GenBank accession No. BAA24933) and PmNramp1 (GenBank 
accession No. AAQ94879)  is shown in fig. 6 and the identity and similarity of the 
compared Nramp homologs are summarized in table 6. It seems that PmNramp1 and 
PmNramp2 display the highest identity in protein sequences (51%). Despite the low 
identity and similarity, conserved domains can be seen from the alignment (Fig. 6). In 
addition, PmNramp1 and PmNramp2 share most of the same exon boundaries in the 
amino acid sequence as indicated by numbered arrows (Fig. 6). 
Table 6 Identity and similarity of PmNramp isotypes 
Identify (Similarity) PmNramp2 PmNramp3 HsNramp2 
PmNramp1 51% (67%) 47% (63%) 35% (51%) 
PmNramp2  40% (56%) 30% (47%) 






















Fig. 6. Multiple alignment of deduced amino acid sequences of PmNramp1, 
PmNramp2 and PmNramp3 with human Nramp2 (HsNramp2).  
Amino acid sequences of PmNramp isotypes were aligned using Mega 4.0 [194, 195] and 
displayed with GeneDoc [196]. Identical residues were highlighted at three cutoffs (50, 
75 and 100 %). Arrows represent the exon boundaries in the protein sequence with the 
number indicating corresponding PmNramp isotype number. 
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PmNramp mRNA is trans-spliced with trans-splicing leader highly identical to 
dinoflagellate splice leader 
Analysis of the 5’ cDNA sequences of PmNramp2 and PmNramp3 revealed a 20 
nt stretch that was absent in PmNramp2 and PmNramp3 genomic vicinities (Fig. 7A). 
Reexamination of the 5’ sequence of PmNramp1 [186] revealed the same feature (Fig. 
7A). This stretch of nucleic acid sequence has a good but not perfect match is displayed 
with the SL sequence from dinoflagellates (Fig. 7B). All mRNA of the three P. marinus 
Nramp genes are trans-spliced with a conserved SL. 
Comparison of genomic DNA and cDNA of PmNramp isotypes revealed that at 
the junction between SL sequence and the 5’ UTR of PmNramp, the genomic DNA 
sequence bears a dinucleotide AG (Fig. 7B) consistent with the common canonical cis- 
and trans-splicing acceptor boundary, apparently serving as the acceptor site of SL [197]. 
In dinoflagellate, a conserved “CGTGTGC” sequence was identified immediately 
upstream of the 3’ acceptor splice site AG of analyzed genes [198]. However, no such 
conserved sequence was found in any of the three PmNramp isotypes. Interestingly, some 
SL sequences from both PmNramp2 and PmNramp3 isotypes carry a thymidine deletion 










Fig. 7. The conserved SL sequence from P. marinus Nramp mRNAs.  
A. alignment of the 5’UTRs of P. marinus Nramp cDNAs and corresponding gDNA 
sequence revealed the 22-nt SL marked by box. The canonical splicing acceptor sites AG 
and the translation starting sites ATG were also highlighted. B. Alignment of the 5’ end 
of PmNramp isotype cDNA. The consensus SL sequence from dinoflagellates is 
compared with that from P. marinus. dino: dinoflagellate consensus SL ( D = T, A or G); 
The 22-nt SL sequence is highlighted by a square box. PmNR1-SL: all the SL sequences 
from three independent clones of PmNramp1 show the same sequence; PmNR2-SL1 and 
PmNR2-SL2: two different SL sequences with a deletion in one of them were obtained 
from three independent clones; PmNR3-SL1, PmNR3-SL2 and PmNR2-SL3: three SL 




Other genes in P. marinus are trans-spliced 
RT-PCR using forward primer designed based on SL sequence and reverse primer 
based on cDNA sequences of P. marinus SOD1, SOD2, APX1, APX2, HSP70 and 
HSP90 generated amplification product that was subsequently sequenced. Sequencing 
result indicates that all the four genes in P. marinus antioxidant pathway, and two of the 
heat shock proteins, HSP70 and HSP90, are trans-spliced with the same SL as in 








Fig. 8. The conserved SL sequence from other genes in P. marinus  
5’ end of P. marinus SOD1, SOD2, APX1, APX2, HSP70 and HSP90 cDNA are aligned 





Trans-spliced P. marinus genes show no obvious transcriptional regulation  
Transcriptional regulation of PmNramp isotypes and P. marinus anti-oxidant 
genes were investigated under several conditions, including iron overload, manganese 
overload, iron depletion, and oyster serum challenge. Transcription regulation of 
PmHSP70 and PmHSP90 were tested under drastic temperature change. There was no 
obvious change in the transcript level for all the tested genes despite the affected P. 
marinus growth under the treatments (Fig. 9 to17).  
P. marinus growth shows no significant difference when the iron concentration is 
as high as 60 times (400 μM Fe) of the standard medium (Fig.9), implying the parasite’s 
capability to adapt to a high-iron environment. A 15-time manganese overload (0.3 μM 
Mn) shows no significant impact on P. marinus growth while a  500-time overload (10 
μM Mn) shows approximately 15% inhibition in cell multiplication. Iron depletion 
caused by 0.01 and 0.08 mg/ml DFO result in a 5% and 12% decrease in growth 
respectively. A 10% reduction in cell growth was induced by 5% oyster serum in the 
medium. For all the tested conditions, the change in Ct value under the challenging 
conditions did not significantly exceed the change in the control group (standard medium 
with no supplements) during the time window of the study. In addition, all the PmNramp 
isotypes and PmSODs transcript gave a highly similar Ct value; while the two PmAPX 
isotypes shared a similar transcriptional level as indicated by the similar Ct value. The 
first-strand cDNA with 10-time dilution was used to test the expression of 18S rRNA 
gene, and it shows the slightest change among all the test genes during the study. In order 
to confirm that the lack of change in transcription indicated by QPCR is not an artifact, P. 
marinus heat shock protein HSP70 and HSP90 transcript were tested when the 
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temperature was changed to 4°C and 37°C for 2 h. There is not significant change in Ct 
values (Fig. 17) despite the possible of HSP protein expression regulation [199]. The 
examination of 5’ cDNA sequences of HSP70 and HSP90 revealed the presence of trans-
splicing leader shown in Fig. 9. The lack of transcription regulation by QPCR reflects the 
probability of constitutive polycistronic transcription suggested by the trans-splicing of 
those genes. Since there was no significant change in Ct values, all the Ct values 


























Fig. 9. Expression of PmNramp1 upon different treatments. 
Ct values obtained by QPCR are indicated in colons and the growth of P. marinus (cell 
number) is indicated by lines. A. iron overload (100 and 400 μM). B. manganese 
overload (0.3 and 10 μM). C. iron depletion by DFO (0.01 and 0.08 mg/ml). D. oyster 
serum challenge (5%).  
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Fig. 10. Expression of PmNramp2 upon different treatments. 
Ct values obtained by QPCR are indicated in colons and the growth of P. marinus (cell 
number) is indicated by lines. A. iron overload (100 and 400 μM). B. manganese 
overload (0.3 and 10 μM). C. iron depletion by DFO (0.01 and 0.08 mg/ml). D. oyster 
serum challenge (5%).  
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Fig. 11. Expression of PmNramp3 upon different treatments. 
Ct values obtained by QPCR are indicated in colons and the growth of P. marinus (cell 
number) is indicated by lines. A. iron overload (100 and 400 μM). B. manganese 
overload (0.3 and 10 μM). C. iron depletion by DFO (0.01 and 0.08 mg/ml). D. oyster 






Fig. 12. Expression of PmSOD1 upon different treatments. 
Ct values obtained by QPCR are indicated in colons and the growth of P. marinus (cell 
number) is indicated by lines. A. iron overload (100 and 400 μM). B. manganese 
overload (0.3 and 10 μM). C. iron depletion by DFO (0.01 and 0.08 mg/ml). D. oyster 




























Fig. 13. Expression of PmSOD2 upon different treatments. 
Ct values obtained by QPCR are indicated in colons and the growth of P. marinus (cell 
number) is indicated by lines. A. iron overload (100 and 400 μM). B. manganese 
overload (0.3 and 10 μM). C. iron depletion by DFO (0.01 and 0.08 mg/ml). D. oyster 



















Fig. 14. Expression of PmAPX1 upon different treatments. 
Ct values obtained by QPCR are indicated in colons and the growth of P. marinus (cell 
number) is indicated by lines. A. iron overload (100 and 400 μM). B. manganese 
overload (0.3 and 10 μM). C. iron depletion by DFO (0.01 and 0.08 mg/ml). D. oyster 



















Fig. 15. Expression of PmAPX2 upon different treatments. 
Ct values obtained by QPCR are indicated in colons and the growth of P. marinus (cell 
number) is indicated by lines. A. iron overload (100 and 400 μM). B. manganese 





























Fig. 16. Expression of Pm18S upon different treatments. 
Ct values obtained by QPCR are indicated in colons and the growth of P. marinus (cell 
number) is indicated by lines. A. iron overload (100 and 400 μM). B. manganese 
overload (0.3 and 10 μM). C. iron depletion by DFO (0.01 and 0.08 mg/ml). D. oyster 








Fig. 17. Expression of PmHSP70 and PmHSP90 transcript upon temperature 
changes. 
Lon-phase P. marinus trophozoites were incubated in three different temperatures. After 





Research work on Nramp was incipiently focused on host homologs mostly 
because Nramp was first identified in mammals as resistance marker [152-154]. After 
that, Nramp homologs were characterized in other animals, plants [156, 159], protozoans 
[186], and bacteria [176, 200], almost all the taxonomic groups. Therefore, Nramp has 
been considered as a molecule that involves in host-pathogen interaction. The number of 
Nramp isotypes varies substantially from organism to organism as mentioned in 
introduction. With regards to protozoan parasites, a single putative Nramp archetype was 
annotated in the genome databases of Plasmodium spp. (http://plasmodb.org/plasmo/), T. 
gondii (http://toxodb.org/toxo/), and Neospora caninum (http://toxodb.org/toxo/, Gene ID 
NCLIV_038890), respectively. PmNramp1 was the first characterized Nramp homolog in 
protozoan parasites. It was considered as a single copy gene in the oyster parasite P. 
marinus based on the Southern blot analysis [186]. In order to answer the question 
whether there are more Nramp isotypes in the parasite, genome mining was performed in 
the P. marinus genome database (http://www.tigr.org/tdb/e2k1/pmg/). Two contigs 
containing partial Nramp homolog were fished out by BLAST using cDNA and amino 
acid sequences respectively. RT-PCR result shows the expression of the three PmNramp 
isotypes, indicating potentially critical functions of these genes in parasite metal 
metabolism during this particular life stage.  
Analysis of the full cDNA sequences reveals the presence of the predicted SL in 
all PmNramp cDNAs. The same SL was found in the 5’end of cDNA of P. marinus 
antioxidant pathway, such as SOD1, SOD2 [14, 15], APX1, and APX2 (unpublished 
data). Trans-splicing has been detected in nematodes, platyhelminths, cnidarians, rotifers, 
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ascidians, appendicularians, and dinoflagellates [197, 198, 201, 202]. This process makes 
it possible to translate polycistronically transcribed nuclear genes. A recent thorough 
investigation of transcript and genomic arrangement of the SL RNA in phylogenetically 
and ecologically diverse dinoflagellates from four different orders reveals that the 
majority of dinoflagellate SL RNA transcripts are 56-59 nt although the size of SL RNA 
can range from 42 to 92 nt. The SL RNA genes are organized in both single gene tandem 
repeats and in mixed SL RNA-5S rRNA arrangements. The highly complex and 
diversified genomic arrangements of SL RNA gene in dinoflagellates is the result of 
genomic duplication and recombination in each dinoflagellate lineage, while the length 
and the secondary structure of the SL RNA is conserved during evolution [203]. However, 
the bigger picture about dinoflagellate spliced leader RNA gene arrangement in genomic 
level is still unavailable. Since P. marinus genome annotation is still underway, it is not 
known if P. marinus has various SL RNA genes with different sequence length and 
genomic arrangement as dinoflagellates. Constitutive polycistronic transcription and 
trans-splicing also occur in flagellated trypanosomatid parasites, including Leishmania, 
Trypanosoma brucei, and T. cruzi [204]. Analysis of the complete genome of L. major 
[205], T. brucei [206], and T. cruzi [207] reveals that majority of genes are organized in 
the form of PGCs (polycistronic gene clusters) in all the chromosomes. A striking 
synteny is observed in the genome of trypanosomatids for protein-coding genes [208]. 
All the genes that reside on the same PGC are transcribed at the same level as the 
consequence of polycistronic transcription [204].  This is a reminisce of the interesting 
result in QPCR that all the PmNramp isotypes and PmSOD isotypes transcript give a 
highly similar Ct value presenting a similar transcriptional level. The questions raised 
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here are first, whether P. marinus genes are organized into PGCs and if so, whether they 
are located in the same PGC. Furthermore, unique machinery for transcription and 
processing of mRNA has been uncovered behind this unique genomic organization in 
trypanosomatid parasites. In L. major, the transcription of the whole chromosome 1 starts 
bidirectionally towards the telomere in the TSS (transcription start sites) between the two 
divergent PGSs [209]. Long G- or C-tracts instead of canonical promoter elements, such 
as TATA box were found in TSSs. The polyadenylation of a gene is dictated by the trans-
splicing of the upstream adjacent gens since the selections of splice site determines that 
selection of the polyadenylation site [210], which can also explain the absence of 
polyadenylation signal in PmNramp genes. The completion of genome annotation of P. 
marinus can answer some fundamental questions about gene expression and regulation of 
the parasite. 
The lack of transcription regulation of PmNramp isotypes implies a significant 
role of post-transcription regulation. In Trypanosoma spp., all the genes are trans-spliced 
[211, 212] and the SL is a conserved 35-nt stretch. The constitutive transcription of all 
the genes makes RNA interference (RNAi) an important avenue for expression regulation 
for the parasite and a widely-used knockdown technique in Trypanosoma research [213-
216]. In the P. marinus genome database, some components of the RNAi machinery have 
been identified by BLAST, indicating a possible regulation of expression through RNAi 
[217]. Acquisition of iron and other divalent cation is vital for P. marinus; therefore, the 
presence of PmNramp mRNA ready for protein synthesis would secure an immediate 
response to metal requirements. P. marinus may have one or two ferritins, based on 
querying the genome with Chlamydomonas reinhardtii ferritin sequences (GenBank 
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accession No. AF503338 and EU223296) [218], suggesting the potential iron storage 
ability and consistent with high-iron tolerance in P. marinus. 
Bioinformatic searches for regulatory RNA elements [219] in either 5’ or 3’ UTR 
of the PmNramp mRNA sequences failed to identify any sequence motifs, such as IRE. 
In vertebrates, the biosynthetic rates for ferritin and the TfR1 are regulated by iron. A 
highly conserved IRE in the 5’ UTR of the ferritin mRNA and the 3’ UTR of mammalian 
TfR1 mRNA mediates iron-dependent post-transcriptional control of their expression 
[213, 214]. A similar element has been reported in the 3’-UTR of vertebrate Nramp2 
sequences [215, 216]. The IRE functions by forming a specific stem-loop structure that 
interacts with IRP in an iron-dependent fashion. Though both animal cytosolic aconitase 
(ACO) and bacterial ACO are able to switch to IRP function, playing a key role in the 
regulation of iron homoeostasis, plant ACO, however, is not converted into an IRP. Thus, 
the absence of IRE in P. marinus may not be surprising since IRP/IRE signaling may 
have been preserved only in metazoans [220]. Nevertheless, it can still be too early to 
exclude IRE/IRP systems as mean of regulation for PmNramp expression. IRE/IRP like 
systems has been reported in some protozoan parasites. In Trichomonas vaginalis [127] 
and Plasmodium falciparum [221], atypical IREs have been identified despite the 
structure deviation compared to the consensus mammalian IRE. Binding activity of the 
IRP-like protein to mammalian IRE was demonstrated in P. falciparum [222, 223] and 
Leishmania tarentolae [137]. The definite function of the IRE/IRP like system in 
protozoan parasites still awaits further investigation 
The regulation of Nramp expression can be realized through different ways for 
different isotypes in a single organism. In yeast, the three Nramp prototypes are regulated 
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differently: the vacuolar iron transporter Smf3 is controlled at the transcriptional level 
[188], while the manganese transporter Smf1 and Smf2 proteins are constitutively 
expressed and trafficked to either degradation or secretory pathways depending on 
manganese availability [224]. Since manganese is so critical for yeast metabolic activity, 
quick response to manganese limitation or toxicity is important. In addition, Nramp 
transporters display broad selectivity for divalent metals, including some that are highly 
toxic. Hence, rapid trafficking of transporters may allow dynamic control of metal-ion 
fluxes, and be beneficial for unicellular organisms. Because all three PmNramp isotype 
transcript lacks known nucleotide sequence motifs and are detected in trophozoites 
cultured in standard conditions, it is possible that the proteins are subject to translational 
and post-translational regulation mechanisms. In addition, the localization of the 
transporters can be changed by protein trafficking so as to regulate the protein function in 
the parasite.  
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CHAPTER 3 PHYLOGENETIC ANALYSIS OF THE 
PMNRAMP ISOTYPES  
SUMMARY 
Phylogeny analysis indicates that the three PmNramp isotypes form a moderately 
tight set of archetype Nramp subgroup II.  They are fairly close relatives of animal and 
higher plant Nramp, and to a less extent to homologues from apicomplexans and ciliates. 
No evidence of positive selection was found among the three isotyes. PmNramp3 stands 
out from the three isotypes when they are subjected to molecular evolutionary analysis. 
By Tajima’s test of relative evolutionary rate, a similar evolutionary rate is shown in 
PmNramp1 and PmNramp2, while PmNramp3 shows a distinct rate; PmNramp1 and 
PmNramp2 display a homogenous substitution pattern, however, PmNramp2 and 
PmNramp3 demonstrate heterogeneous pattern. It seems that PmNramp genes evolved by 
successive duplications of PmNramp2, first yielding PmNramp3 and more recently 
PmNramp1. Protein sequence divergence among PmNramp isotypes was not related to 
diversification of critical functional elements, which remained constrained by purifying 
selection. This result is in consistence with the function of both PmNramp1 and 
PmNramp3 as iron transporter in yeast despite their different evolutionary rate and 
substitution patterns.  
                                                 




Five Nramp phylogroups were identified to provide a plausible pathway 
describing the evolution of the Nramp family, from sodium- or proton-motive substrate 
symport in bacteria, to metal nutrition, eukaryotic host cell defense and brain function 
[225]. Among the five subgroups of Nramp, the most ancient homologs are prokaryotic 
MntH B that can date back to the apparition of anoxygenic photosynthetic organism. 
With the increase of the oxygen concentration in the atmosphere, MntH A homologs 
merge during the aerobic organism evolution. The origin of eukaryotic prototype Nramp 
is likely to be MntH A, which is transfer to Eukaryotes due to an endosymbiotic event.  
Early gene duplication of prototype Nramp gives rise to archetype Nramp. Close 
relationships between MntH C group and some prototype Nramp, and within MntH C 
group irrespective of bacterial phylogeny, indicate eukaryotic gene transfer toward 
bacteria [226]. However, no direct eukaryotic source of mntH C genes has been identified 
to date, and this complication warrants careful phylogenetic studies of Nramp homologs 
in unicellular eukaryotes. Therefore, a hypothetic evolutionary pathway of Nramp is 
presented as Outgroup > MntH B > MntH A > eukaryotic duplication/divergence of 
proto- and archetype Nramp > MntH C (C , C , C ) [227].   
The current taxonomic distribution of Nramp phylogenetic subgroups is the 
outcome of the Nramp evolution combined with the selective loss of certain subgroup in 
certain organisms. MntH A homologs are broadly shared, while mntH B genes are 
prevalent among anaerobic genera. The distribution of MntH C ranges from wide (MntH 
Cα) to limited to gut-associated bacteria (MntH Cβ) or Gram negative soil bacteria 
(MntH Cγ).  In eukaryotes, the taxonomic distribution of both archetype and prototype 
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Nramp is diverse, including Bikonts (Plantae, Chromoalveolates) and Unikonts 
(Amebozoa, Fungi and Animals; [226, 228]).  Though subgroup I of Nramp archetype 
comprises homologs found in monocots and eudicots plants, Nramp archetype subgroup 
II is shared by organisms from both Unikonta and Bikonta.  Prototype Nramp display 
more restricted distribution (Amebozoa and Fungi, green and red Algae and lower plants, 
e.g., bryophytes), which seems to be the result of selective loss of this isoform in animals, 
higher plants (monocots, eudicots) as well as in Chromoalveolates; in contrast, most 
fungi lost archetype Nramp isoforms, except some species that diverged basally. 
Four different approaches have been used to phylotype PmNramp1 and other 
putative apicomplexan Nramp homologs (Plasmodium falciparum, P. yoelii and 
Toxoplasma gondii). It was indicated that PmNramp1 and apicomplexan Nramp genes 
share a same archetype Nramp ancestor; while, apicomplexan Nramp, especially 
Plasmodium spp. Nramp, is obviously divergent from other archetype Nramp. It seems 
that the closest homologues of PmNramp1 and apicomplexan Nramp are plant and 
Dictyostelium discoideum homologues [228]. With the identification of the extra two 
PmNramp isotypes, the phylogeny of PmNramp is revisited in this chapter. In addition, 
the evolution of the three PmNramp isotypes is proposed. 
MATERIALS AND METHODS 
Phylogenetic analysis  
To phylotype the three PmNramp, a representative set of eukaryotic homologs 
was selected to generate multiple alignments using full-length amino acid sequences and 
the softwares Clustal X [229]or Muscle [230], which were edited manually and used 
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alternatively to compare phylogenies.  Sets of parsimony-informative sites 
(corresponding to at least two different amino acids, and at least two of them occuring 
with a minimum frequency of two, [195]) were also examined as an alternative to full-
length sequences to examine tree robustness.  A consensus phylogenetic tree was 
established by implementing several approaches using different substitution models.  The 
rate of amino acid variation among sites was modeled using the WAG amino acid 
substitution matrix [231] and a discrete Gamma distribution [232]. Phylogenies were 
inferred using three different types of calculations: i) changes probabilities along the tree 
branches were determined by Quartet Puzzling and Maximum Likelihood using Tree-
Puzzle (Schmidt HA & A von Haeseler, 2007); ii) pairwise evolutionary distances 
(numbers of substitutions) were deduced by using the Minimum Evolution/Neighbor-
Joining method [233] and allowing heterogeneous pattern of substitution across the 
lineages [234]  as well as pairwise or complete deletion modes [195]; iii) Maximum 
Parsimony [235] was used to deduce the evolutionary transitions required to explain the 
observed amino acid distributions [195].  The consistency of each calculation was 
estimated by bootstrapping ([236]; 3000 replicates) and the confidence score of tree 
nodes was compared.   
To evaluate the type of selective pressure exerted on Perkinsus gene sequences, 
Kumar’s modification of the Pamilo-Bianchi-Li method was used to analyze the relative 
abundance of synonymous (S) and nonsynonymous (N) substitutions in codon-by-codon 
pairwise comparisons (Fig. 18 and 19) of the three aligned PmNramp nucleotide 
sequences [195, 237].  After estimating the number of synonymous substitutions per 
synonymous site (dS) and the number of nonsynonymous substitutions per 
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nonsynonymous site (dN) as well as their variances, Var(dS) and Var(dN), the level of 
significance at which the null hypothesis of neutral evolution (H0:  dN = dS) may be 
rejected was tested considering three alternative hypotheses (AH1: dN  dS, strict 
neutrality; AH2:  dN > dS, positive selection; AH3:  dN < dS, purifying selection).  A two-
tailed Z-test was used to determine the level of significance of the difference dN - dS 
(AH1) and a one-tailed Z-test was applied to examine the other hypotheses (AH2,3).  
Both pairwise and complete site-deletion options were used to compare the results 
obtained; the variance of the difference dN - dS was calculated by bootstrap resampling 
(3000 replicates).  
Molecular evolutionary gene analyses 
The molecular clock hypothesis was evaluated using Tajima’s relative rate test, 
which implies equality of evolutionary rate between two sequences, irrespective of a 
substitution model and whether or not the substitution rate varies among sites [195, 238].  
Pairs of PmNramp nucleotide or amino acid sequences were compared, using the third 
sequence as an outgroup.  Tajima’s method uses a chi-square (χ2) test to estimate the 
independence of paired observations on two variables; a value of the corresponding 
probability (p < 0.05) was used to reject the molecular clock hypothesis.  
Homogeneity of substitution patterns was derived from pairwise sequence 
comparisons using the Disparity Index test, which calculates the extent of differences in 
base or amino acid residue composition between sequences.  The probability p of 
rejecting the null hypothesis that sequences evolved with the same pattern of substitution 




Tridimensional structural models were obtained for PmNramp 1 and 3 using the 






Fig. 18. Amino acid alignment of the three PmNramp isotypes 
The alignment was generated using Mega 4.0 [195] and displayed with GeneDoc [196]. 
Identical residues are highlighted at three cutoffs (50, 75 and 100 %). The N-terminal 
sequences of PmNramp isotypes are omitted to avoid the variation caused by the 




























Fig. 19. Codon-by-codon cDNA alignment of PmNramp isotypes 
The cDNA sequences of PmNramp isotypes are aligned codon-by-codon based on the amino acid alignments in Fig. 18. The 






RESULTS AND DISCUSSION 
Taxonomic distribution of Nramp in eukaryotes 
A linearized phylogenetic tree showing key nodes supported by high bootstrap 
values obtained by different methods is presented in Fig. 20.  The three Perkinsus Nramp 
sequences (PmNramp1-3) form a moderately tight set among other homologs that 
together constitute Nramp archetype subgroup II.  The three PmNramp thus represent 
fairly close relatives of animal Nramp, similarly to the homologs found in most other 
Chromoalveolate genomes to date, including some Stramenopile spp. (e.g., PsoNR1a, Fig. 
20 and Table 7), and to a lesser extent those from Apicomplexans and Ciliates, which 
appear more divergent (e.g., Tthe1-3, Fig. 20).  Also, the diatom Thalassiosira possesses 
an Nramp homolog (TpseNR) resembling more the archetype I found in Plantae. 
Assuming a hypothetical common ancestry for Chromoalveolates and Plantae [241-243], 
this might suggest an ancient origin for Nramp archetype I and II paralogs in Bikonta, 
and selective loss of subgroup I in most Chromoalveolates.   
The distribution of prototype and archetype Nramp in both Unikonta and Bikonta 
suggest an ancient origin/duplication corresponding to early stages in the emergence of 
eukaryotic cells.  To verify this possibility a taxonomically broad database of expressed 
sequence tags (TBestDB, [244]) was searched by Blast analyses using prototype and 
archetype Nramp as queries; individual eukaryote databases of the DOE JGI genome 
portal were queried as well.  The results presented in Table 10 show that archetype 
Nramp are present in several species of Chromoalveolates (Dinoflagellates; 
Apicomplexans: Hemisporozoans and Coccidians; Stramenopiles: Oomycetes and 
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Pelagophyceae; Haptophytes), as well as in Plantae (archetype I or II, Rhodophytae, 
Chlorophytae), Amoebozoa, basal Fungi (Mucoromycotina, Zygomycota) and Eumetazoa.   
Regarding prototype Nramp, several DNA sequences found in Bikonta (Excavata: 
Jakobids and Euglenoids; Plantae: Glaucophytae and Chlorophytae) represent potential 
candidates, albeit derived from 3’ mRNA ends, which encode parts of Slc11 transporters 
that are little conserved and thus yielding weakly supported relationships (Fig. 21 B).  
However, phylogenetic analyses performed with the 5’ ESTs enable to distinguish Nramp 
prototype from archetype I with confidence (Fig. 21 A).  Together with prior data 
obtained with full-length sequences, the present results thus support the conclusions that 
the duplication and divergence of proto- and archetype Nramp, and the later 
diversification of archetype Nramp in subgroups I and II, both predated the emergence of 
Unikonta and Bikonta.  Subsequently, organisms independently conserved one type or 
another or both.  In Alveolata, it is the Nramp archetype II that was selectively retained, 








Fig. 20. Simplified phylogeny of PmNramp1-3 
The consensus tree presented was obtained using Mega 4.0 [195]; it was linearized by 
assuming equal evolutionary rate among lineages [245] and drawn to scale by calibration 
using a time of divergence between Nramp1 and 2 of 350 million years ago [185]. 
Phylogeny was inferred using a set of 340 parsimony-informative sites derived from full-
length sequence initially aligned with the Muscle algorithm; the Minimum Evolution 
method was implemented based on distances computed using the Equal Input amino acid 
substitution model [246] and considering both differences in the composition bias among 
sequences and rate variation among sites modeled with a gamma distribution (shape 
parameter = 1.41). The percentage (>50%) of replicate tree nodes inferred from 3,000 
bootstrap samplings are indicated while less reproducible partitions were collapsed. 
Percentage replicates of the main nodes (divergence of proto- and archetype Nramp; 
archetype I and II Nramp) obtained by other approaches are also indicated (Maximum 
Parsimony and Maximum Likelihood, Fig. 22 B & C). The non-linearized version of this 
phylogenetic reconstruction is presented in Fig.  24 A, together with those produced by 
other approaches (Fig. 22 B & C) as well as using full-length sequences (Fig. 22 D & E). 
Following are indicated the SLC11 phylogroups (bold) and full names of the organisms 
(italics) included in this analysis: Outgroup: CellO, Cellulophaga; MntH B: CacetB, 
Clostridium acetobutylicum, CtepiB, Chlorobium tepidum; Prototype Nramp: ScSmf1-3, 
Saccharomyces cerevisiae, LbicNR1, Laccaria bicolor, RoNR1a, Rhizopus oryzae, 
BdenNR1, Batrachochytrium dendrobatidis, CreNR, Chlamydomonas reinhardtii , 
PhysNR1, Physcomitrella patens, DdNR1, Dictyostelium discoideum, CmNR1, 
Cyanidioschyzon merolae; Archetype Nramp, type I: OsjNR1,3, Oryza sativa japonica, 
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TpseNR, Thalassiosira pseudoana, CmNR2, C. merolae, OtauNR, Ostreococcus tauri; 
Archetype Nramp, type II: TtheNR1-3, Tetrahymena thermophila, PblaNR2, Phycomyces 
blakesleeanus, PmNramp1-3, Perkinsus marinus, PsoNR1a, Phytophthora sojae, DdNR2, 
D. discoideum, OsjNR2, O. sativa japonica , PhysNR2, P. patens, MbreNR, Monosiga 
brevicollis, ReniNR, Reniera, NvecNR, Nematostella vectensis, HsNR1,2, Homo sapiens. 
The distribution of the taxa sampled is given in Table 7.
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Table 7. Taxonomic distribution of known eukaryotic Nramp homologs 
Taxa Species Prototype Nramp Archetype Nramp  I II 
           Hemisporozoan Plasmodium (6)   1 Neospora   1 
           Coccidian Toxoplasma   1 
      Apicomplexan     
      Dinoflagellates Perkinsus   3 Ichthyophthirius   2 
      Ciliates Tetrahymena   3 
   Alveolata     
      Pelagophyceae 
Aureococcus   2 
Hyaloperonospora   1 
Saprolegna   1 
      Oomyceta Phytophthora (2)   1-4 
      Diatoms Thalassiosira  1  
  Stramenophiles     
  Haptophyta Emiliana   1 
Chromoalveolata     
          Spermatophytae   1-2 2-4 
Embryophytae 
Marchantia 1 1-  
Physcomitrella 1-  2- 
Chlorella   1 
Micromonas  1  
Ostreococcus (2)  1  
Volvox 1   
Chlamydomonas 2   
       Chlorophytae Scenedesmus 2   
  Viridiplantae     
  Rhodophytae Cyanidioschyzon 1 1  Glaucocystis 1   
  Glaucophyteae Cyanidioschyzon 1   
Plantae     
  Euglenoids 
 
Euglena 1   
Reclinomonas 1   
  Jakobids Seculamonas 1   
Excavata     
               Bikonta     
               Unikonta     
Amoebozoa     
  Tubulinea Hartmanella  1  
  Mycetozoa Dictyostelium (2) 1  1 Physarum 1  1 
Opisthokonta     
  Fungi     
     Mucoromycotina Cunninghamella   1 
Chytridiomycota Spizellomyces 1   Batrachochytrium 1   
Zygomycota Rhizopus 2  2 Phycomyces 2  2 
      Basidiomycota 
Ustilago 1   
Cryptococcus 1   
Phanerochaete 2   
  Ascomycota Neurospora 1   Candida 4   
  Eumetazoa     
   Porifera Reniera   1 
      Cnidaria Nematostella   1 
       Metazoa Monosiga   1 M. ovata 1   














Fig. 21.  Phylogenetic analyses of sequences derived from taxonomically diverse 
unicellular eukaryotes demonstrate prevalence of prototype Nramp (pN).  
The taxonomic distribution of the species studied is indicated in Supp. Table 2. Amino acid 
sequences deduced from expressed sequence tags (TBestDB) [244] and corresponding to either 
5’ (A) or 3’ (B) parts of suspected prototype SLC11/Nramp mRNAs were analyzed together with 
full-length control sequences of bacterial SLC11 homologs of eukaryotic origin [226], MCα, 
MntH Cα; Opitutus terrae (Verrucomicrobium), Rhizobium etli (α-proteobacterium), F. johnsonii 
(Flavobacterium) as well as Archetype I Nramp homologs (aN I) from the red alga C. merolae 
and the diatom T. pseudoana. These dendrograms were generated as described in Fig. 20 but 
without molecular clock assumption, and using the pairwise deletion option and a gamma 












Phylogeny of Perkinsus Nramp1-3 proteins 
Assessment of the Nramp protein phylogeny (Fig. 20 and 21), regarding in 
particular the level of sequence divergence among PmNramp homologs as well as 
between this set and other Nramp archetype II, indicates two main properties: i) 
compared to their Alveolatan relatives, in Apicomplexans and Ciliates, the PmNramp 
sequences did not diverge extensively from the other members of the archetype II group; 
and, ii) compared to other unicellular organisms that possess multiple genes, the extent of 
apparent divergence among PmNramp polypeptides (e.g., PmNramp3) appears 
significant.   
First, the absence of the PmNramp sequence set from the cluster formed by the 
Nramp from Ciliates and Apicomplexans (Fig. 22 D & E) was unexpected, based on the 
commonly accepted phylogeny of Dinoflagellates as sister group of Apicomplexans, and 
the more basal divergence of Ciliates (Moore RB et al., 2008, Sanchez-Puerta & 
Delwiche, 2008, Nash EA et al., 2008); however this result may be a simple consequence 
of variations in DNA maintenance and overall GC percent, which is very low in both 
Ciliates and Apicomplexans.  Secondly, PmNramp paralogs appeared consistently more 
divergent than T. thermophila paralogs in various phylogenetic trees (longer branches for 
PmNramp paralogs, Fig. 19 and Fig. 21); even though similar patterns were observed in 
both species, with two homologs relatively close and another more distant.  The extent of 
sequence divergence among Perkinsus Nramp resembled more that existing between 







Fig. 22. Detailed phylogeny of P. marinus Nramp homologs (PmNramp1-3) 
demonstrates they belong to the Nramp Archetype II group.  
A. The dendrogram presented was generated as described in Fig. 20 but without the 
molecular clock assumption, and using additional sequences which showed more 
significant disparity in amino acid composition bias (Archetype Nramp, type II: PfalNR, 
Plasmodium falciparum, PvivNR, P. vivax, PberNR, P. berghei, TgoNR, Toxoplasma 
gondii, EhuxNR, Emiliana huxleyi; Prototype Nramp: UmayNR, Ustilago maydis; 
Outgroup: NphaO). B & C. Dendrograms generated using the same set of sequences and 
parsimony-informative aligned sites as in (A), by implementation of Maximum 
Parsimony (B) and Maximum Likelihood (C) approaches. D & E. Dendrograms 
generated using full-length sequences (same set as (A-C), 1136 sites) and a gamma 
distribution shape parameter = 1.0; D, Minimal evolution; E, Maximum Likelihood. 
Scales indicate the number of amino acid substitutions per site.          
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Analysis of Perkinsus Nramp1-3 gene evolution 
Closer examination of PmNramp sequence variation was undertaken to address 
specifically the possibility of functional divergence between PmNramp3 and PmNramp1 
and/or 2.  Regarding the closely related PmNramp1 and PmNramp2 genes, analyses of 
the relative abundance of synonymous and nonsynonymous substitutions in codon-by-
codon pairwise sequence comparisons showed that the hypothesis of strict-neutrality 
could be rejected (dN - dS = -5.554, p=0.000 using pairwise deletion, and dN - dS = -6.264, 
p=0.000 for complete deletion) in favour of the alternative hypothesis of purifying 
selection (dS - dN = 5.45, p=0.000 for pairwise deletion and dS - dN = 6.056, p=0.000 for 
complete deletion).  Second, Tajima’s test of relative rate of exchange between aligned 
sequences supported the molecular clock hypothesis, i.e., similar evolutionary rates for 
PmNramp1 and 2 genes (χ2 test values of 0.89, p = 0.346, for nucleotide sequences, and χ2 
test values of 0.11, p = 0.745, for amino acid sequences).  Third, estimation of the 
homogeneity of substitution pattern per site between aligned sequences indicated 
homogeneous protein sequences (Disparity index null), as well as homogeneous 
nucleotide sequences (Disparity index < 0.260, with p > 0.1, excepted for the third 
position of the codons).  Thus, PmNramp1 and 2 gene sequences are homogeneous, 
evolving at similar rates under purifying selection that favors synonymous substitutions.   
PmNramp3 sequence relationships with PmNramp1 or 2 contrasted with the 
similarities between the two latter.  Hence, the relative abundance of synonymous and 
nonsynonymous substitutions between PmNramp3 and PmNramp1 or 2 were similar, 
suggesting neutral evolution; Tajima’s test of constancy of evolutionary rates between 
PmNramp3 and PmNramp1 or PmNramp2 sequence yielded χ2 test values respectively of 
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57.56, p = 0.00000 and 71.87, p = 0.00000 enabling to strongly reject the molecular clock 
hypothesis.  In fact, PmNramp3 sequence exhibited high counts of unique transitions and 
transversions (133 and 210) relatively to PmNramp1 (86 and 85) or PmNramp2 (77 and 
77).  Applying then Tajima’s test to amino acid sequences confirmed different rates of 
evolution for PmNramp3 compared to PmNramp1 or 2 (χ2 test values of 30.83, p = 
0.00000 and 27.61, p = 0.00000).  In addition, PmNramp3 was distinguished from 
PmNramp1 by measuring the heterogeneity of substitution pattern per site in pairwise 
sequence alignments with PmNramp2.  The disparity index between PmNramp3 and 2 
was independent of the third codon position, and it was also significant using the protein 
sequences (0.449, p = 0.019), while borderline non-significant heterogeneity was detected 
between PmNramp3 and PmNramp1 protein sequences, or between the mRNA sequences 
when using only the two first codon positions.  
Detailing evolutionary patterns of Perkinsus Nramp1-3 genes domains 
These results obtained using full-length sequences suggested that purifying 
selection and more or less ancient gene duplications, yielding first PmNramp2 and 3, and 
then PmNramp1, may explain the observed sequence relationships of PmNramps.  To 
validate our interpretation, Tajima’s rate test was employed to analyze less variable 
subsets of sites, spanning either the four TMS believed to constitute the transmembrane 
cations core conductive pathway (TMS1, 3, 6, 8) or the five successive TMS constituting 
a domain repeat (N-terminal: 1-5, and C-terminal: 6-10) but excluding the more variable 
extra-membranous regions (N- and C-termini as well as the extra-loop 7/8).  These sets of 
sites differ by increasing sequence divergence, respectively ~ 25, 42 and 50 % and 
notably, in the proportion of sites divergent in all three sequences (~5, 9 and 19 %).   
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These amino acid data sets showed fairly constant proportions of isoform-specific 
sites, similar for PmNramp1 and 2, and about two-fold more for PmNramp3.  
Heterogeneous substitution patterns per site were found among PmNramp1 and 2 (N-
terminal domain, 0.232, p = 0.036) and between PmNramp2 and 3 (C-terminal domain, 
borderline significance, 0.299, p = 0.055).  Significant evolutionary rate variations were 
detected with the most divergent data sets (C-terminal domain) and involved PmNramp3 
and PmNramp1 or 2 (χ2 test values of 7.41, p = 0.00649 in both cases).   
Corresponding nucleotide sequence analyses revealed for the most conserved data 
sets (predicted translocation pathway and N-terminal domain) homogeneous substitution 
patterns per site, and purifying selection between PmNramp2 and 3 (respectively, dS - dN 
= 2.272, p=0.012 and dS - dN = 2.042, p=0.022, for pairwise deletion); purifying selection 
between PmNramp1and 2 was also confirmed with the three data sets (the predicted pore 
and both N- and C-domains, respectively, dS - dN = 3.064, p=0.001, dS - dN = 2.357, 
p=0.010 and dS - dN = 2.128, p=0.018) as expected from full-length sequence analyses.  
Lastly, Tajima’s evolutionary rate tests showed significant pairwise differences with all 
data sets only when PmNramp3 was tested (predicted pore: χ2 test value of 9.56, p = 
0.00199 vs. PmNramp1 or 2; N-terminal domain: 10.64, p = 0.00111 vs. PmNramp1 or 
11.92, p = 0.00055 vs. PmNramp2; C-terminal domain: 16.56, p = 0.00005 vs. 
PmNramp1 and of 14.3, p = 0.00016 vs. PmNramp2).   
Overall the results of domain analyses enable us to conclude that the four TMS 
forming the predicted translocation pathway are submitted to strong purifying selection, 
which was detected by comparing PmNramp2 and PmNramp1 or PmNramp3 coding 
sequences and demonstrating homogeneous substitution patterns per site between all 
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three gene and protein sequences; only PmNramp3 nucleotide sequence showed 
differences in evolutionary rate compared to PmNramp1 or PmNramp2.  Regarding the 
continuous N-terminal domain that spans TMS 1-5, purifying selection was still detected 
in comparisons using PmNamp2 coding sequence, but at the amino acid level, distinct 
substitution patterns per site were noted between PmNramp1 and 2 as well as almost 
significant evolutionary rate difference between PmNramp1 and 3.  Considering the C-
terminal domain without the extra-loop 7/8, significant variation in nucleotide 
substitution pattern was found between PmNramp2 and the two other genes; the 
corresponding variation in amino acid disparity index between PmNramp2 and 3 was 
borderline significant, while PmNramp3 exhibited significantly different amino acid 
substitution rate, though the evolution of this protein sequence remained neutral.   
We therefore conclude that the presence of three PmNramp genes is consistent 
with sequential gene duplications of PmNramp2 yielding first PmNramp3, and more 
recently PmNramp1.  PmNramp3 is the most divergent homolog among the three 
PmNramp isotypes, but this divergence may not be related to functional diversification. 
The yeast complementation data are consistent with the phylogeny test since both 
PmNramp1 and PmNramp3 function as iron transporter. The functional data reinforce the 
proposed PmNramp1 homologous structural model, and together with the molecular 
evolutionary gene analyses indicating that the hydrophobic core of PmNramp paralogs 




CHAPTER 4 FUNCTIONAL CHARACTERIZATION OF 
THE PMNRAMP ISOTYPES 
 
SUMMARY 
Yeast mutant strain fet3fet4 has defect in both high- (fet3) and low-affinity (fet4) 
iron transporters. Yeast complementation assay using fet3fet4 indicates iron uptake 
activity of PmNramp1. PmNramp2 and PmNramp3 cannot complement fet3fet4 growth 
in low iron conditions. Expression of PmNramp isotypes in yeast was investigated. It was 
found out that PmNramp2 cannot be transcribed in yeast. PmNramp3 protein was 
expressed in a much lower level compared to PmNramp1. Subcellular localization of 
PmNramp1 by IFA showed a cell peripheral localization, which is absent in PmNramp3 
immunostaining. A PmNramp1 and PmNramp3 chimera made by substituting the 
predicted PmNramp3 N- and C-termini with the corresponding part of PmNramp1 was 
expressed in the peripheral of yeast cells as accessed by IFA. Chimeric PmNramp3 was 
able to complement fet3fet4 growth in the medium without iron supplement, indicating 
iron transport function of PmNramp3.  
 
INTRODUCTION 
Knowledge about Nramp transport substrate comes from studies performed in 
different expression systems: 1) Xenopus oocyte expression system [247] 2) yeast 
complementation assay [247, 248] 3) mammalian cell lines [165, 249] 4) knockout or 
knockdown of endogenous genes [250]. There are pros and cons in the three different 
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methods. Xenopus oocyte electrophysiology studies are relatively expensive and require 
dedicated facilities to hold the animals. Demonstration of metal accumulation in the 
oocyte, in most of the case by measuring of radioactive isotope is needed after the 
electrophysiology studies. The advantage is that several metal substrates can be tested by 
exposing mRNA-injected oocytes to the substrate of interest. Yeast complementation is a 
low-cost one-step experiment compared to Xenopus oocyte electrophysiology study; 
however, a particular mutant strain is required for particular substrate at most cases. 
Mammalian cell lines are usually used in iron uptake study in virtue of fluorescence dye 
calcein that can get into the live cell and be quenched after binding to iron. It is possible 
that exogenous Nramp from another species cannot be expressed properly in 
heterologous systems, which make knockout/knockout of Nramp a valuable strategy if 
those molecular tools are available.  
In this chapter, yeast complementation assays were performed to test the potential 
iron and manganese transport activity of PmNramp isotypes. The expression and function 
of PmNramp isotypes in yeast were investigated in details. 
MATERIALS AND METHODS 
Yeast strains and plasmid 
Yeast mutant fet3fet4 was kindly provided by Dr. Eide (University of Wisconsin-
Madison, USA) and Dr. Jones (Queensland Institute of Medical Research, Australia). 
This yeast strain grows poorly under iron-limiting conditions because it has mutated low-
affinity and high-affinity iron transporters (MATα; ura3; trp1; leu2; his3; can1; fet3:: 
HIS3; fet4:: LEU2) [251, 252]. 
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For the test of manganese transport activity, the yeast mutant smf1smf2 was 
provided by Dr. Gros (McGill University, Canada). Smf1smf2 mutant cannot survive 
EGTA challenge in submillimolar concentration under oxidative stress since the high-
affinity manganese transporter is inactivated (MATa ura3–52 leu2–3 -112 gal2 
SMF1::LEU2, SMF2::LEU2) [253]. It also grows poorly in alkaline medium. 
To express PmNramp isotypes in yeast, the corresponding CDS with HA tag in C-
terminus was cloned into the NotI site of the expression vector pFL61 (a gift from Dr. 
Jones, Queensland Institute of Medical Research, Australia), which has an active yeast 
GPK (glycogen phosphorylase kinase) promoter. 
Culture and transformation of yeast cells 
 Fet3fet4 yeast cells were first streaked onto YPAD agar (10g/L Bacto yeast 
extract, 20g/L Bacto peptone, 20g/L D-glucose, 40mg/L adenine hemisulphate, 20g/L 
Bacto agar) supplemented 50 μM FeCl3. After 3 to 4 days of growth, yeast cells from the 
agar medium were inoculated into YPAD liquid medium with 50 μM FeCl3 and 
incubated over-night at 30°C with shaking (250 rpm). Yeast was transformed using 
lithium acetate method [254] and selected for growth on synthetic-defined (SD) medium 
(6.7 g/L yeast nitrogen base, 20g/L D-glucose, 20 mg/L L-tryptophan, 20 mg/L L-
histidine, 30 mg/L L-leucine, 20 mg/L methionine, 20 mg/L adenine hemisulphate, 20 
g/L Bacto agar, pH 5.6), which is appropriate auxotrophic requirements.  
Transformation and expression of PmNramp isotypes in transformed yeast  
Total DNA was extracted from transformed yeast cells using the QIAamp tissue 
kit (Qiagen) following the manufacturer’s instructions. Extracted DNA was used for the 
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confirmation of the vector existence by PCR using PmNramp isotype specific primers 
and pFL61 vector primer (Table 8). Total RNA was extracted from the transformed yeast 
cells with the RNeasy Mini Kit (Qiagen). RT-PCR was performed to examine the 
expression of PmNramp mRNA in yeast using gene specific primers (Table 2). Yeast 
cells were ruptured by glass beads. The enriched membrane fraction of yeast protein was 
prepared by 1% Triton X100 in Tirs buffer and SDS sample buffer for Western blot to 
test the expression of PmNramp protein using monoclonal anti-HA antibody 3F10 
conjugated with biotin (Roche Applied Science, Indianapolis, IN) and strepatavidin-
peroxidase (Sigma).  
Table 8. Primers used in N- and C-terminus swapping and yeast complementation 
Construction of chimeric PmNramp2 and PmNramp3 
To test the metal transport capacity of PmNramp2 and PmNramp3, their N- and 
C-termini were swapped with counterparts of PmNramp1 (Fig.23). For N-terminus 
swapping, a BamHI restriction site was introduced by PCR in the coding regions of all 
the three isotypes, using the primers indicated in Table 8.  To verify that introducing of 
this restriction site dose not perturb PmNramp1 function, PmNramp1 with the BamHI site 
was included as a control in yeast complementation assays. For C terminus swapping, an 
MscII site was identified upstream of PmNramp1 TMS12, and was introduced to the 
corresponding positions in PmNramp2 by PCR with the primers listed in Table 8. An 
Primers Sequences PCR reactions 
pFL61F 5’- GTTTTTCAAGTTCTTAGATGC-3’ Screening for yeast transfectants 
pFL61R 5’- AGCGTAAAGGATGGGG-3’ 
BamHI-PmNR3core 5’- GGATCCCGTTACGCCGGCCCGGGATG-3’ Terminus swapping in 
PmNramp3 SphI-PmNR3coreR 5’- GCATGCCAACTCAGACTGCACTGCTG-3’ 
BamHI-PmNR2core 5’- GCATGCCAACTCAGACTGCACTGCTG-3’ Terminus swapping in 
PmNramp2 MscI-PmNR2coreR 5’- TGGCCAATCTAAGGGGACCAGTGTAG-3’ 
BamHI-PmNR1core 5’- GGATCCAAGTATGCTGGTCCTGGTTG-3’ Insertion of BamHI site in 
PmNramp1 BamHI-PmNR1coreR 5’- GGATCCCTTAGCACCGGGCGGGTCAA-3’ 
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SphI site was found in the same proximal region of PmNramp1.  For the replacement of 
PmNramp3 C-terminus, the SphI site was added into PmNramp3 CDS. The graphic 
demonstrations about domain swapping are in Fig. 23. Despite the changes in amino acid 
sequence of PmNramp2 and PmNramp3 after domain swapping due to insertion of the 
restriction sites, the core structures from TMS1 to TMS10 were kept intact in both 













Fig. 23. N- and C-termini swapping of PmNramp1 to PmNramp2 and PmNramp3 
A BamHI site was introduced to PmNramp2 (PmNR2swap) and PmNramp3 
(PmNR3swap) for N- terminal swapping. The same BamHI site was introduced to 
PmNramp1 (PmNR1swap) to verify that the mutation does not perturb PmNramp1 
activity. For C-terminal swapping, an MscI site and an SphI site in PmNramp1 was used 
for PmNramp2 and PmNramp3 domain swapping respectively. The core structures 














IFAs to detect PmNramp protein expression in fet3fet4 
Fet3fet4 yeast cells transformed with PmNramp1, PmNramp3 and chimeric 
PmNramp3 were harvested for IFAs. Cells were fixed in 4% formaldehyde in SD 
medium at room temperature for 30 minutes. After that, yeast cells were centrifuged at 
3000 g for 5 minutes and washed three times in 0.1 M potassium phosphate buffer 
containing 1.2M sorbitol (pH 7.5). In the same buffer, yeast cell wall was digested by 50 
μg/ml lyticase (Sigma) at 30°C for 5 hours.  Cells were centrifuged, re-suspended in PBS 
with 3% BSA, applied to the slide wells (Thermo Scientific), and allowed to sediment for 
40 minutes. Cell were dehydrated 6 minutes in cold methanol (-20 °C), washed in cold 
acetone (-20 °C) for 10 seconds, and dried at room temperature. IFA was performed as 
follows. Every sample is incubated with 3% PBS-BSA as blocking agent in room 
temperature for 1 h. Primary antibody mouse anti-HA, monoclonal 16B12 (Invitrogen) 
was added into 3% PBS-BSA in 1:100 dilution and incubated with every sample for 1 h 
at room temperature. After three washes in PBS for 5 minutes, secondary antibody (goat 
anti-mouse FITC conjugated) (Sigma) was added into 3% PBS-BSA in 1:1000 dilution 
and incubated in dark for 1h at room temperature. After three washes in PBS for 5 
minutes, samples were stained with DAPI (Invitrogen, Carlsbad, CA) in 1:1000 dilution 
for 10 minutes followed by 3 washed in PBS. ProLong Gold antifade reagent (Invitrogen) 
was applied onto each sample as the mounting solution, and the slide was stored in dark 
at 4 °C. The samples were examined using Nikon Eclipse E800 fluorescence microscope, 
and images of the cells were taken with SPOT RT2540 camera (Diagnostic Instruments, 




Yeast complementation assay of transformed fet3fet4 
Complementation experiments in fet3fet4 mutant were performed following 
methods of Eide and colleagues [252]. The Arabidopsis thaliana ferrous iron transporter 
(AtIRT1) [255] known from previous yeast complementation assays to be an efficient 
Fe2+ transporter [248], was incorporated into pFL61 vector (gift from Dr. Jones, 
Queensland Institute of Medical Research, Australia) and was used as positive control. 
As a negative control, yeast was transformed with pFL61 vector alone.  
Transformed yeast was grown in SD medium supplemented with 50 μM FeCl3 
over night. Yeast cultures were adjusted to OD=1.0 measured by UV- Visible 
spectrophotomerter (Shimadzu, UV-1601). 3 μl of yeast cultures diluted 1, 10, and 100 
times was pipette onto SD agar medium supplemented with 50 μM, 20 μM and 0 μM 
FeCl3, and incubated at 30 °C. After 5 days of incubation, the pictures of the agar plates 
were taken using Gel Logic 200 Imaging System (Kodak). For iron uptake assay in liquid 
medium, 100 μl yeast cultures with OD 1.0 were seeded into 30 ml fresh SD medium 
with 20 μM FeCl3 and incubated at 30 °C with shaking (250 rpm). OD values were 
measured at different time points using UV-visible spectrophotometer in triplicates.  
Complementation assay of yeast smf1smf2 
The same expression vector pFL61was used for expression of PmNramp isotypes 
in smf1smf2. The transfection procedures were the same as mentioned above. The yeast 
Nramp homolog Smf1 was incorporated into pFL61 vector and used as a positive control. 
Transformed cells were grown on YPD (2% bacto-peptone, 1% yeast extract, 2% 
dextrose) supplemented with 50 mM Na-Mes (pH 6), 0.5 mM methyl viologen (Sigma) 
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and 3mM EGTA.  For complementation of the sm1smf2 mutant on alkaline solid medium, 
transformed yeast cells were placed on YPD medium adjusted to pH 7.9 by 50 mM Tris-
Cl.  
RESULTS 
Expression of PmNramp isotypes in fet3fet4 
PCR of genomic DNA extracted from transformed fet3fet4 showed amplification 
of PmNramp-containing pFL61 vectors (Fig. 24 A). RT-PCR using PmNramp isotypes 
specific primers confirmed the transcription of PmNramp1 and PmNramp3 mRNA (Fig. 
24 B), but not PmNramp2 RNA. Western blot using anti-HA monoclonal antibody picked 
up expressed PmNramp1-HA and PmNramp3-HA (Fig. 24 C). As shown in the results, 
only PmNramp1 and PmNramp3 were expressed as protein, however, PmNramp1 protein 
was expressed in a higher level than PmNramp3. The predicated sizes for PmNramp1 and 
PmNramp3 are 60.7 KDa and 60.0 KDa respectively (http://expasy.org/cgi-bin/pi_tool). 
While the indicated sizes in Western blot (Fig. 24 C) for PmNramp3 is much bigger than 
60.0 KDa, which can be the result of anomalous migration of membrane proteins in SDS-
PAGE. The multiple bands and the smear in the blot for PmNramp1 can be also due to 
the anomalous migration and potential carbohydrate modification of the protein.   
The expression of PmNramp proteins in yeast cells were tested by immunofluorescence 
assays (Fig. 24 D). Consistent with the western blot results, PmNramp3 is expressed, but 
not in a high level as PmNramp1. PmNramp1 is localized both inside the cell and also in 









Fig. 24. Transformation and expression of PmNramp isotypes in fet3fet4. 
A. Transformation of PmNramp isotypes in yeast. Genomic DNA (gDNA) extracted 
from yeast transformed with PmNramp1 (lane 1), PmNramp2 (lane 2), PmNramp3 (lane 
3) full-length cDNA or pFL61 (lane 4) was used as template in PCR to confirm the 
presence of PmNramp containing vector in yeast cells  
B. Transcription of PmNramp isotypes in yeast. RT-PCR was performed to check the 
expression of PmNramp1 (lane 5), PmNramp2 (lane 6) and PmNramp3 (lane 7) mRNA 
in yeast.  
C. Western blot of PmNramp isotypes in yeast. Enriched membrane fractions were 
prepared from yeast transformed with PmNramp1 (lane 8), PmNramp2 (lane 9), 
PmNramp3 (lane 10) or pFL61 (lane 11), separated by 12% SDS-polyacrylamide gel 
electrophoresis, and probed by immunoblotting with the anti-HA high-affinity 3F10 
antibody conjugated with biotin and strepatavidin conjugated with horseradish peroxidase.  
D. IFA of PmNramp1 and PmNramp3 in fet3fet4 yeast cells. All the PmNramp isotypes 
were tagged with HA epitope. Monoclonal mouse anti-HA antibody and anti-mouse 
antibody conjugated with FITC were used to visualized PmNramp1 and PmNramp3 





PmNramp1 complements the growth of fet3fet4 
In SD agar medium supplemented with 0 and 20 μM FeCl3, fet3fet4 expressing 
PmNramp1 grows better than yeast that contains the empty cloning vector (Fig. 25 A). 
The growth of yeast transformed with PmNramp1 entered the exponential growth much 
earlier than cells transformed with pFL61 vector alone (Fig. 25 B), thereby demonstrating 































Fig. 25. Yeast complementation assay of PmNramp isotypes in fet3fet4 
Fet3fet4 yeast cells were transformed with the three PmNramp isotypes or positive 
control AtIRT1, which were all inserted in the expression vector pFL61. Cells were also 
transformed with the empty expression vector as negative control. The transformed yeast 
cells were subjected to complementation assays in both agar and liquid medium. A, 
growth of serially diluted yeast cells after 5 days incubation at 30°C on SD medium 
supplemented with 50, 20, or 0 μM FeCl3. B, growth in liquid SD medium supplemented 





Fet3fet4 complementation assay of chimeric PmNramp2 and PmNramp3  
Based on the previous study in Nramp protein family, the N- and C- termini of 
NRAMP could be closely related to the expression and localization of the protein in a 
heterologous system [256, 257]. Following the same line of thought, since PmNramp1 
can be properly expressed in fet3fet4, the N- and C- termini of PmNramp1 was swapped 
to PmNramp2 and PmNramp3 without interrupting any of the predicted TMS1-10 (Fig. 
23). The chimeric PmNramp3 was expressed in the yeast cell peripheral (Fig. 26 A), and 
PmNramp3 showed a significant complementation activity in both solid and liquid 
medium after domain swapping (Fig. 26 B, C). Chimeric PmNramp2 cannot be obtained 
in 4 independent transformation of yeast fet3fet4. The result implies that both PmNramp1 



















Fig. 26. Complementation of iron deficiency phenotype of yeast fet3fet4 mutant by 
chimeric PmNramp3. 
A, IFAs of chimeric PmNramp3. The chimeric PmNramp3 was tagged with HA epitope. 
Monoclonal mouse anti-HA antibody and anti-mouse antibody conjugated with FITC 
were used to visualized PmNramp1 and PmNramp3 protein localizations in yeast cells. 
Nucleus positions were indicated by DAPI staining. Yeast cells transformed with empty 
pFL61 vector was used as negative control. 
B, Yeast complementation assays of chimeric PmNramp3 in solid medium. Serially 
diluted cells transformed with PmNramp1 and chimeric PmNramp3 after domain 
swapping (PmNramp1swap & PmNramp3swap) were incubated 5 days at 30°C on SD 
medium supplemented with 50, 20 or 0 μM FeCl3.  
C, Yeast complementation assays of chimeric PmNramp3 in liquid medium. Yeast cells 
transformed with PmNramp1 and chimeric PmNamp3 were incubated in liquid SD 









Yeast complementation assay in smf1smf2 
Under the treatment of EGTA and oxidative stress induced by methyl viologen, 
smf1smf2 yeast cells transformed with PmNramp1 grow better than yeast cells 
transformed with empty vector, PmNramp2, and PmNramp3 (Fig. 27 A). However, there 
was not obvious complementation by PmNramp1 when yeast cells were grown under the 





























Fig. 27. Complementation assay of yeast strain smf1smf2 in solid medium.  
Smf1smf2 yeast were transformed with expression vector pFL61 containing Smf1, 
PmNramp1, PmNramp2 or PmNramp3 tagged with HA or pFL61 vector alone. A, 
Growth of serially diluted cells after 5 days at 30°C on SD medium containing 3mM 
EGTA. B, Growth of transformed yeast cells after 5 days at 30°C in YPD medium (pH 




The data showing that PmNramp1 is able to complement iron transport activity in 
yeast constituted the first piece of information about iron uptake in P. marinus. The 
function of PmNramp1 as manganese transporter remains to be further investigated since 
the data in yeast complementation is not yet confirmative. Nramp homologs usually have 
a wide substrate range with high affinity to divalent iron and manganese [184]. Most of 
the Nramp homologs identified so far can transport both iron and manganese although 
some of them have a preferred substrate. Another heterologous expression system may be 
needed to further investigate manganese transport function of PmNramp1. If manganese 
is not a physiologically-related substrate for PmNramp1 in P. marinus, there are potential 
manganese uptake pathways.  BLAST searches in P. marinus genome data base using 
amino acid sequences of yeast PHO84 and A. thaliana MTP11 suggest a potential low-
affinity manganese transporter (GenBank Accession number XP_002781691) PHO84 
[258] and a CDF (Cations Diffusion Facilitators) Metal Tolerance Proteins MTP11 
(Accession number XP_002777192) that has a signature DXXXD domain for manganese 
transport [259]. 
Although PmNramp1 was able to complement iron uptake in fet3fet4, PmNramp2 
and PmNramp3 indicate no complementation in yeast. The lack of complementation by 
PmNramp2 is caused by the problematic expression of the gene, and the failure of 
complementation by PmNramp3 is probably because the protein cannot be targeted to 
yeast cell surface (Fig. 24). In previous studies of Nramp function in heterologous 
systems, substitution of N- and C-termini with other Nramp homologs was key to 
improve the expression and change subcellular compartment localization. A chimera of 
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yeast smf1 with mammalian Nramp2 termini was made to enable electrophysiology study 
in Xenopus oocytes [257, 260]. Based on the model of MntH [240], the hydrophobic core 
formed by TMS1-10 is closely related to substrate transport, and TMS11 and TMS12 
may serve as anchors for the molecule. The N- and C-domain substitution strategy was 
adopted to circumvent the expression problem of PmNramp3. Since PmNramp1 can be 
expressed in yeast, a PmNramp1 and PmNramp3 chimera with an intact hydrophobic 
core formed by PmNramp3 TMS1-10 was generated. The chimera demonstrated an iron 
uptake function in fet3fet4. The results is consistent with the prediction by evolutionary 
studies (Chapter 3) that the protein sequence divergence among the three PmNramp 
isotypes is probably not related to the diversification of critical function elements, since 
PmNramp3 showing the greatest divergence in amino acid level can function as iron 
transporter as PmNramp1. 
The functional studies in yeast systems implies the possibility that PmNramp1 
may serve as the surface transporter for the uptake of environmental iron while 





CHAPTER 5 STRUCTURAL AND MECHANISTIC 
STUDIES OF THE PMNRAMP ISOTYPES 
 
SUMMARY 
Homology modeling of PmNramp1 predicted the 12 transmembrane segments 
(TMS) typical of the archetype Nramp proteins, and showed symmetric organization of 
the conserved hydrophobic core (TMS1-10) in two repeated domains of inverted 
topology typical of several families of cation-driven transporters (including Slc5 and 
Slc6). The center position of the Slc11-specific triplets Asp-Pro-Gly (TMS1) and Met-
Pro-His (TMS6) in a three-dimensional arrangement formed with TMS3 and TMS8 
provides the mechanistic basis for iron acquisition via PmNramp1. Mutations of the 
residues in the central triplets located in TMS1 and TMS6 abolished the complementation 
of fet3fet4 by PmNramp1. Mutants with mutations on TMS1 were expressed in a much 
lower level compared to wild-type PmNramp1 protein, and mutants with mutations on 
TMS6 showed a similar expression level. IFAs revealed that mutations on TMS6 did not 
change the protein localization as compared to the wild-type PmNramp1. Therefore, our 
data supported the critical functional roles played by the residues on TMS6.  
 
INTRODUCTION 
The function of transporters is intimately determined by their transmembrane 
arrangement, which enables them to carry solutes. Genetic studies using prokaryotic and 
138 
 
eukaryotic Slc11  homologs and various topological reporters have yielded a consensus 
transmembrane topology placing both ends of the Slc11 hydrophobic core (TMS1-10) on 
the cytoplasmic side of the membrane, but some extra-membranous loops remain to be 
tested experimentally [188, 261-263].  The global Slc11 transmembrane topology also 
fits a predicted tridimensional fold, which is conserved among apparently distant families 
of Na+- and H+- dependent transporters showing less than 15% overall amino acid 
sequence identity, including Slc6, [264], Slc5, [265], Slc23, [240, 266], and Slc7 [267]. 
Obtaining consistent models by threading using structural templates unrelated by 
sequence may thus provide, even with moderate accuracy due to remote homology, good 
structural indication of functional significance.  
Nramp homology modeling was performed by threading Slc11 sequences onto a 
structure representative of Na+-coupled amino acid transporters (Slc6), and it was tested 
both functionally and topologically using several Slc11-specific mutants of E. coli MntH 
[240]. Further threading using available resources and the ever expanding RCSB Protein 
Data Bank (PDB; http://www.rcsb.org/) confirmed this model, because three novel 
structures that were solved for members from apparently unrelated families of cation-
driven transporters revealed a conserved architectural fold [265-267]. 
According to such conserved tridimensional structure, the Slc11 hydrophobic core 
comprises two domains that are direct repeats with inverted topology.  The two specific 
triplets Asp-Pro-Gly (TMS1) and Met-Pro-His (TMS6) would occupy the central position 
                                                 




and together with segments of TMS3 and TMS8, form a three-dimensional arrangement 
enabling directional cation symport [264-266].  The TMS1 Asp-Pro-Gly motif 
contributes to proton-binding and -motive force, shown by the loss of H+ uptake in E. coli 
MntH Asp34 mutants, while the TMS6 Met-Pro-His motif mediates pH-dependent 
regulation consistent with requirement for E. coli MntH His211 for Cd2+ uptake at neutral 
pH.  These two Slc11-invariant sites were accessible in situ, respectively to fluorescein-
maleimide and N-ethylmaleimide, while three others were not, corresponding to 
transmembrane Asn residues that could mediate inter-helix interactions key for transport 
[240].  
The similar structures solved for the transporters Mhp1, LeuT, vSGLT and ApcT 
appear to represent discrete steps in a ‘gated-pore’ transport cycle common to diverse 
families of cation-driven carriers, respectively open-to-out, open-to-out and ‘occluded’ 
by substrate and closure off from external bulk water, and open-to-in [264-267]. Hence, 
utilization of a cation-motive force to symport substrate may constitute the functional 
activity that preserved a common architecture among many families of solute carriers in 
absence of obvious sequence similarity. These structures also revealed an internal 
symmetry with two 5 TMS repeats assembled in inverted orientations placing the 
cosubstrates binding sites at the apex of a cavity formed in part by TMS 1, 3, 6 and 8. 
In this chapter, 3D models of PmNramp1 protein were proposed by homology 
modeling. The 3D models provided a mechanistic basis for the iron transport activity of 
PmNramp1 as implied by the functional studies in Chapter 4. To test the accuracy of the 
models, the predicted central residues involved in substrate translocation were mutated by 
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site-directed mutagenesis, and the resulted mutants were tested by yeast complementation 
assays.  
 
MATERIALS AND METHODS 
Structural analysis of PmNramp1 by homology modeling 
 Tridimensional structural models were obtained as previously described [240] for 
the three PmNramp isotypes using either MODELLER with consensus restraints, or with 
the default parameters of the programs developed by the Zhang laboratory including 
iterative TASSER simulations (I-TASSER)[239], with the default parameters of the 
programs developed by the Zhang laboratory including the Local Meta-Threading-Server 
(LOMETS) [268], which  generates 3D models by collecting consensus target-to-
template alignments from 9 locally-installed threading programs, the MUlti-Sources 
ThreadER (MUSTER) [269], which combines sequence profile-profile alignment with 
multiple structural information. The PDB coordinates calculated by the different 
programs were used with the freeware viewer Pymol (DeLano WL: The PyMOL 
molecular graphics system, http://www.pymol.org) to visualize the 3D models. 
Site-directed mutagenesis 
To test the structural/functional value of the predicted model and the importance 
of the canonical triplets in TMS1 and TMS6 for PmNramp1 function, selected amino acid 
resides were mutated by site-directed mutagenesis using QuikChange II site-directed kit 
(Stratagene, Santa Clara, CA). The primers used for introducing the mutations are listed 
141 
 
in Table 9. All mutations were confirmed by sequencing the plasmids prior to the yeast 
complementation assay. Expression and subcellular localization of mutated PmNramp1 
protein in fet3fet4 was assessed by Western blot and IFAs 
Yeast cells were ruptured by glass beads. The enriched membrane fraction of 
yeast protein was prepared by 1% Triton X100 in Tirs buffer and SDS sample buffer for 
Western blot to test the expression of PmNramp protein using monoclonal anti-HA 
antibody 3F10 conjugated with biotin (Roche Applied Science, Indianapolis, IN) and 
strepatavidin-peroxidase (Sigma). IFAs were performed as described in Chapter 4.               
Table 9. Site directed mutagenesis of PmNramp1 
 TMS Mutations Primers 
Mut1 TMS1 Asp76Glu 5’- CATTGGCCTATCTCGAACCTGGTAATTTAGAAGCCG -3’ 
Mut2 TMS1 Gly78Ala 5’- CATTGGCCTATCTCGATCCTGCTAATTTAGAAGCCG -3’ 
Mut1&2 TMS1 Asp76 Glu+ Gly78Ala 5’- CATTGGCCTATCTCGAACCTGCTAATTTAGAAGCCG -3’ 
Mut3 TMS6 Met250Ala 5’- GGCGCAGTTATTGCTCCGCATAACCTCTACCTGCAC -3’ 
Mut4 TMS6 His252Tyr 5’- GGCGCAGTTATTATGCCGTATAACCTCTACCTGCAC -3’ 
Mut3&4 TMS6 Met250Ala + His252Tyr 5’- GGCGCAGTTATTGCTCCGTATAACCTCTACCTGCAC -3’ 
 
RESULTS 
Functional features predicted from protein sequence structural modeling analysis  
Multiple alignments of the sequences encoding the PmNramps and human 
Nramp2 proteins (Fig. 28) show residue conservation predominantly in the Slc11 
                                                 




hydrophobic core and invariant residues forming clusters in areas corresponding to the 
TMS1-10. This conservation suggests that PmNramps may function as transporters which 
complete transmembrane (re)arrangements to carry solutes by using energy.  
Fig. 29 shows the best models obtained by threading PmNramp1 sequence on 
available PDB templates, which detail alternating conformation states presumed to affect 
PmNramp1 TMS1, 3, 6, and 8 during metal uptake activity, based on the solved 
structures of Mhp1 [266] and vSGLT (Vibrio parahaemolyticus sodium/galactose 
symporter) [265]. An open-to-out conformation would allow cation cosubstrates to reach 
their translocation site, approximately in the middle of the plasma membrane and 
involving the Slc11-specific residues Asp-Pro-Gly (TMS1) and Met-Pro-His (TMS6) as 
well as other residues from TMS3 and 8. After the PmNramp1 isomerisation, an open-to-
in conformation would enable the release on the other side of the membrane of the cation 
solutes.  As shown in Fig. 28, clusters of residues invariant among PmNramps are found 
along these TMS predicted to line a central transmembrane aqueous translocation 
pathway (TMS1, 3 , 6, 8) supporting their functional role.  
The sequence of the “conserved transport motif” (indicated by dash line, Fig. 28) 
is now predicted as integral to TMS8 in the tridimensional Slc11 model structure 
obtained by threading [240, 263]. Such “conserved transport motif” was initially 
proposed to form a cytoplasmic re-entrant loop, situated immediately downstream of a 
shorter TMS8, and predicted to contribute to cations selection by analogy with the “pore 
region” of K+ channels and glutamate and GABA transporters [270]. This suggestion was 
re-evaluated because i) the “pore region” of the GABA and serotonin transporters 
corresponds in fact to the TMS8 in LeuT-based models [271, 272], and ii) indeed, the 
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GABA transporter “pore region” was demonstrated experimentally to form a 














Fig. 28. Display of predicted structure by alignment of PmNramp isotypes with 
human NRAMP2. 
Amino acid sequences alignment of human NRAMP2 with the three PmNRAMP 
isotypes. The predicted TMS are annotated. The conserved “transporter signature motif” 
is indicated by dash line. The triplets in TMS1 and TMS6 were indicated by red boxes. 
The alignment was generated using Mega 4.0 [194, 195] and displayed with GeneDoc 








Fig. 29.  Hypothetic model for transmembrane symport of divalent metals and 
protons via PmNramp1.  
A short version of PmNramp1 (Pm1_NCD, 485 residues; VKFSF…. EDLMG) was used 
to generate alignments that mapped PmNramp1 residues to homologous sites in candidate 
template crystal structures, using the parameters provided by the developers of multiple 
threading approaches, and models generated by two different approaches were compared. 
The models shown were derived either from Microbacterium liquefaciens nucleobase-
cation- symport1 transporter, in open-to-out conformation (A), or from the Vibrio 
parahaemolyticus sodium/galactose symporter, in open-to-in conformation (B). Two 
views are presented for each model as indicated, one from the external surface (outside) 
and one parallel to the membrane with the TMS 4 and 9 in front. For each view, either the 
485 residues structure is shown or only the residues that constitute the TMS1, 3, 6 and 8.  
A possible pathway of metal and proton symport is outlined. 
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Site-directed mutagenesis of PmNramp1 predicted functional residues 
A multiple alignment allowing flexibilities was obtained for the X-ray structures 
of 5 cation-driven transporters with inverted symmetry, which represent distinct 
intermediates in a conserved transporter cycle: 2 open to out, one occluded from both 
sides and 2 open to in (respectively, Mhp1, LeuT, BetP, SGLT1 and ApcT). Though 
these X-ray structures represent distant families of transporters, superposition 
demonstrates remarkable spatial conservation: a common core spanning ~200 equivalent 
positions (e.p.) and 3.4 Å overall Root Mean Square Deviation (RMSD). The RMSD is 
not distributed homogenously along the 10TMS hydrophobic core and for instance, 
TMS1 exhibits remarkable 3D conservation while the structure of TMS6 apparently 
evolved with less constraint (Fig. 30 A, left panel).  It seems there is a functional 
correlate as LeuT (Slc6) TMS1 interacts with both the driving cation (dark blue sticks) 
and substrate (orange sticks) and TMS6 only binds the substrate (orange sticks). One 
speculation is that TMS6 evolved more in relation to different substrate geometries and 
TMS1 coupled of the cation-driving force and substrate translocation pathway. The 
triplets targeted for mutagenesis represent candidate substrate binding contacts both on 
TMS1 (DPG, Mut1, 2) and TMS6 (MPH, Mut3, 4). 
Mutation of the targeted amino acids in TMS1 and TMS6 abrogate PmNramp1 
iron uptake activity in the yeast mutant fet3fet4. The loss of complementation resulted 
from both single and double mutations on each of the TMS (Fig. 30 C, D). Inspection of 
protein expression levels of the mutants tested showed that mutations in TMS1 impaired 
PmNramp1 expression in yeast, while mutations in TMS6 preserved PmNramp1 
heterologous expression levels (Fig. 30 A, right panel). Therefore, because the TMS1 
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mutant protein was expressed in a much lower level than the wild type, it is not possible 
at this time to establish a strong correlation between the losses of complementation by 
TMS1 mutants to the functional roles of the mutated resides in iron uptake. In contrast, in 
addition of showing similar expression levels, IFAs revealed that mutants in TMS6 
showed a similar localization in yeast cells as compared to the wild type PmNramp1 
protein. Therefore, the failure of complementation by TMS6 mutants is likely to result 
from the disruption of the iron transport mechanism caused by the mutation of those 






































Fig. 30. Complementation assays of yeast fet3fet4 mutant after mutations of key 
residues in PmNramp1.  
A, Left panel, view of superimposed TMS1 and TMS6 of carriers from 5 evolutionary 
distant families (Mhp1, LeuT, BetP, SGLT1 and ApcT) showing LeuT residues engaged 
in substrate binding (orange sticks) and those interacting with the driving-cation (Na2 site, 
dark blue sticks); the corresponding sites in other transporters are represented with yellow 
and light blue sticks, respectively. The areas targeted for mutagenesis are indicated. Right 
panel, western blot of the membrane-enriched extract from yeast cells transformed with 
mutated PmNramp1.  
B, IFAs of yeast cells transformed with TMS6 mutants. All the PmNramp1 mutants were 
tagged with HA epitope. Monoclonal mouse anti-HA antibody and anti-mouse antibody 
conjugated with FITC were used to visualized protein localizations in yeast cells. 
Nucleus positions were indicated by DAPI staining. 
C, Left panel, growth of serially diluted cells transformed with PmNramp1 with 
mutations at TMS1 after 5 days at 30°C on SD medium supplemented with 50, 20 or 0 
μM FeCl3. Right panel, growth of TMS1 mutants in liquid SD medium supplemented 
with 20 μM FeCl3.  
D, Left panel, growth of serially diluted cells transformed with PmNramp1 with 
mutations at TMS6 after 5 days at 30°C on SD medium supplemented with 50, 20 or 0 






Yeast complementation assay suggested the iron uptake function in PmNramp1 
and PmNramp3. Following the concept that protein function is the reflection of protein 
structure, we modeled PmNramp1 3D structure by homologous threading (Fig. 29). The 
3D model of PmNramp1 fits the iron complementation activity in the yeast. As a further 
confirmation of the model, mutations on the central triplets Asp-Pro-Gly (TMS1) and 
Met-Pro-His (TMS6) of PmNramp1 abolished the complementation. It turned out that 
mutants with mutated TMS1 triplet were not expressed properly compared to wild-type 
PmNramp1; while mutants with mutated TMS6 triplet were expressed as normally as 
intact PmNramp1. Therefore, the failure of complementation may be due to the structure 
interference while the interruption of complementation by mutants in TMS6 is probably 
due to the functional damage. It seems that mutations in TMS1 have a greater impact on 
PmNramp structure.  Although the equivalent TMS1 mutants in the E. coli MntH or 
mouse Nramp2 are efficiently expressed in the homologous cells, causing significantly 
impaired transport activity; when transformed into yeast, the mouse Nramp2 D86A 
mutant exhibits a noticeable reduced expression [273]. These observations suggest that 
although the mutation in TMS1 does not affect Nramp expression in the homologous 
cells, it can severely impair expression in the heterologous system. Mutation in TMS6 
seems to have little impact in Nramp homolog expression in either homologous or 
heterologous expression system. In a recent study on E. coli MntH, site-directed 
mutagenesis of several highly-conserved residues in TMS6, including those tested here, 
kept endogenous expression in a moderate to normal level compared to wild type [274].  
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Mouse Nramp2 with mutated TMS6 tripeptide could be stably expressed in smf1smf2 
yeast and CHO (Chinese hamster ovary) cells [256]. 
Substitution of Asp34 in MntH with Gly or more conservative Asn can abolish 
both Me2+ and H+ transport [275, 276]. Equivalent mutant Asp86Ala in mouse Nramp2 
failed to complement yeast strain smf1smf2; the same mutant showed no metal transport 
activity in CHO cells [273]. Consistent with those reports, our result about PmNramp1 
mutant Asp76Glu supported the key role of the Asp residue in Nramp function. The other 
residue Gly78 in PmNramp1 TMS1 was indicated to be necessary in this site. The 
equivalent mutation was tested in E. coli MntH [276] and mouse Nramp2 [256]. 
Regardless of the nature of the substitution, mutation in the corresponding Gly site 
resulted in the loss of function. In TMS6 triplet, the Met residue seems to be 
indispensable. Substitution of this residue with Ala in PmNramp1 abrogated the 
complementation function as iron transporter. Substitution of the corresponding Met 
residue in E. coli MntH with either Ile or Lys demolished transport activity despite the 
similar side chain volumes of Met and Ile [274]. Site-directed mutagenesis of His residue 
in TMS6 triplet seems to have a mild effect on transport function, and the nature of the 
substitution can have different impact. The choices of amino acid for substitution of the 
targeted residue could be made on different basis. Some of the substitutions that appeared 
in the literature were chosen based on the evolutionary analysis and the others were based 
on the biochemical features of the amino acid residues. Chaloupka et al. made the His211 
residue to Tyr mutation in -E. coli MntH that is equivalent to PmNramp1 His252 
substitution in this study, since tyrosine is the most prevalent substitution for this residue 
in the phylogenetic outgroup [275]. This mutation significantly reduced the sensitivity of 
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E. coli growth under toxic concentration of metals. Proton uptake of H211Y mutant was 
detected only with the substrate Cd2+. Substitution of H211A imposed a milder effect on 
MntH function. E coli carrying this mutation showed a higher sensitivity to toxic metal 
compared to H211Y mutant, albeit at a reduced level compared to wild type; the co-
transport of proton and metal were restored [275]. Tyr possesses an acid side chain while 
His exposes a basic imidazole group, and therefore, mutation of His to Ala is more 
neutral compared to substitution with Tyr. In mouse Nramp2, the equivalent residue 
His267 was characterized to be highly mutation sensitive. Substitution with Ala, Cys and 
Arg all resulted in severe or complete loss of function. Lower pH conditions seem to 
restore the transport activity of mutant His267A, while decreasing pH has little effect on 
the function of wild type mouse Nramp2. Therefore, the hypothesis was raised that His211 
might involve in pH-dependent regulation of MntH transport activity [273]. While 
Haemig and colleagues argued that their result did not support the pH regulation function 
of the equivalent His residue in E. coli MntH. They pointed out that His211 did not play a 
critical role in Mn2+ binding because substitution at this site kept Km values similar to 
wild type. In addition, lower pH did not give obvious advantage to the mutant H211Q in 
transport activity as seen in mouse Nramp2 mutant H267A [274]. The divergence in 
results can caused by the difference in the nature of substitution (H267A, H267C, and 
H267R by Lam-Yuk-Tseung et al.; H211A, H211Y by Chaloupka et al.; H211Q by 
Haemig et al.). Secondly, the data on mouse Nramp2 were generated in heterologous 
expression systems, including yeast and CHO cells. Despite the difficulty in judgment of 
the actual function of His residue in TMS6 triplet, it can still be concluded that this 
residue is closely involved in Nramp homolog function. 
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In summary, the results from our functional studies buttress the relevance of the 
TMS 1 and 6 predicted to exert pseudo-symmetric roles in substrate transport, and 
support a possible direct role of TMS6 residues in iron uptake. These results provide 
novel evidence consistent with the 3D model for the Slc11 family that is based on remote 
homology with cation-driven transporters with inverted symmetry. Sequence divergence 
among PmNramp homologs correspond predominantly to regions predicted extra-
membranous (Fig. 22), which can nevertheless harbor site-specific signals for protein 
localization and/or turnover. Distinct Lys residues in yeast Smf1p N-terminal hydrophilic 
sequence are targeted for Rsp5p dependent ubiquitination to promote endocytosis in 
response to external cadmium [277] and to toxic manganese [278]. These observations 
suggest that divergent sequences amongst PmNramp extra-membranous regions may still 
contain residues useful for post-translational regulation of expression, subcellular 
localization and trafficking of PmNramps in response to environmental metals. Although 
PmNramp1 failed to transport manganese, because most Slc11 homologs show relatively 
low selectivity for divalent metals it is possible that PmNramps can transport other metals. 
Constitutive mRNA expression of PmNramp1-3 in trophozoites in vitro, and extensive 
protein sequence variation in extra-membranous regions raise a possibility for dynamic 
post-translational control of expression, location and turnover of PmNramps. One 
possible scenario is that PmNramp1 might function as the prominent isotype for uptake 
of exogenous iron into the parasite cells, whereas PmNramp2 and PmNramp3 could 
function downstream of PmNramp1 for intracellular iron trafficking in relocation and 
storage. The key finding that PmNramp1 functions in uptake of exogenous iron in yeast 
provides the molecular and biochemical basis for prior observations on the effect of 
157 
 
environmental iron in enhancing infection prevalence and intensity, promoting parasite 
proliferation. The identification of PmNramp1 as a potential mediator of parasite 










The subcellular localization of PmNramp isotypes was investigated via IFA. Anti-
serum against selected antigenic peptides from PmNramp isotypes was raised in rabbits. 
The IgG fraction was purified from the serum and tested for specificity by Western blot. 
Based on the Western blot result, PmNramp1 and PmNramp3 were expressed in cultured 
P. marinus while PmNramp2 expression was no detected.  
IFAs of PmNramp isotypes in P. marinus trophozoites are still in progress. The 
IFAs of PmNramp3 in log-phase trophozoites, showed a cell surface staining when the 
parasite proliferates by binary fission. These data indicated potential roles of PmNramp3 
in parasite growth. 
 
INTRODUCTION 
A number of organisms are known to have multiple Nramp genes. Three Nramp 
isotypes haven been identified in the ciliate protozoan Tetrahymena thermophila, the 
baker yeast Saccharomyces cerevisiae, and the nematode Caenorhabditis elegans. The 
three T. thermophila Nramp homologs were annotated in the genome database.  n S. 
cerevisiae, Nramp homologs Smf1p and Smf2p perform non redundant roles as 
manganese transporters, with Smf1p mediating rapid massive influx at the plasma 
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membrane and Smf2p in charge of down-stream manganese utilization. Differently, Smf3 
in S. cerevisiae plays a role in iron homeostasis [188].  Three C. elegans Nramp 
homologs are identified and Smf1 and Smf3 are expressed in intestine, functioning as 
manganese transporters and as part of innate immunity in the nematode [250]. Based on 
previous data, two of the three P. marinus Nramp homologs, PmNramp1 and PmNramp3 
can function as iron transporters (Chapter 3). Information about PmNramp1 and 
PmNramp3 localization in the parasite can shed some light on the in vivo function of the 
transporters. 
The detailed life cycle of P. marinus is not yet clearly documented. Ultrastructural 
features of in vitro P. marinus culture were studied by Sunila, et al. (2004) [279]. During 
vegetative cell cycles, P. marinus cells divide either by schizogony or binary fission with 
the formal one being the common way of proliferation [279]. A graph about different cell 
types during P. marinus schizogony was presented in Fig. 31. Different cell types can be 
distinguished based on morphology and size. Large log-phase trophozoites (16 μm in 
diameter) are characterized by eccentric nuclei. Large log-phase trophozoites then 
develop to young log-phase schizonts with subdividing cytoplasm compartmentalized by 
daughter cell walls. After completion of schizogony, young log-phase schizonts turn to 
mature log-phase schizonts (20 μm in diameter), characterized by clear vacuoles and 
spherical nuclei. Despite the completion of division, the daughter cells are still bounded 
by the common schizont cell wall. After 24h, these daughter cells are released and 
become small log-phase trophozoites (5 μm in diameter) that develop to large log-phase 
trophozoites when there is plenty of nutrition in the medium. When the parasite 
population is large, the nutrients in the culture medium are depleted and metabolites from 
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the log-phase growth are built up. P. marinus growth enters the stationary phase. Mature 
log-phase schizonts become stationary-phase schizonts (10 μm in diameter) and small-
log phase trophozoites turn into stationary-phase trophozoites [279]. 
In this chapter, subcellular localizations of PmNramp homologs were examined. 
Parasite cell from both exponential and stationary growth phases are investigated to test 
the possible life-stage dependent change in protein trafficking. In C. elegans, Smf1 has 
different expression patterns in embryo and adult nematodes [250]. Since both 
PmNramp1 and PmNramp3 can potentially function as iron transporters (Chapter 4) and 
iron is an essential element for P. marinus growth [10, 11], DFO chelation challenge is 







Fig. 31. A diagrammatic drawing of cell cycle of cultured P. marinus.  
A. Large log-phase trophozoites in DME/F12 based medium. B. Young log-phase 
schizonts or internally subdividing mother cells containing daughter cells. C. Mature log-
phase schizonts with daughter cells in a common schizont cell wall. D. Small log-phase 
trophozoites ready for the next division cycle. E. Stationary-phase schizonts limited by 
scarce nutrients. F. Stationary-phase trophozoites (modified from Sunila et al., 2001).  
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MATERIALS AND METHODS 
Generation of PmNramp antibodies 
Rabbit antiserum (Open biosystems, Huntsville, AL) was raised against selected 
peptides on all the three PmNramp isotypes. The selected peptides are predicted to be 
part of the topological loop between TMS7 and TMS8 as indicated in Fig. 32. IgG 
subgroups were purified from both anti-serum and pre-immune serum using Protein A 
sepharose 4B (Sigma) and stored in PBS containing 0.02% NaN3. The purified IgG 
antibodies were tested in Western blot by comparing the results from anti-serum IgG and 
pre-immune IgG. Because the pre-immune serum for PmNramp1 was missing, membrane 
extract from yeast cell fet3fet4 transformed with HA-tag PmNramp1 was used to test 
purified PmNramp1 IgG. Monoclonal anti-HA antibody was used as a reference to detect 
PmNramp1 protein as described in Chapter 3. All the Western blots were performed 
using chemiluminescent detection (Pierce Biotechnologies, Rockford, IL) of HRP-







Fig. 32. Rabbit antiserum was raised against peptides predicted to be the loops 
between TMS7 and TMS8. 
Amino acid sequences of PmNramp isotypes aligned using MEGA 4.1 and displayed by 
GeneDoc. The peptides selected to raise antiserum are indicated in red box. The positions 
of TMS based on the 3D model (Chapter 5) were indicated by lines. The selected 
peptides are part of the loop between TMS7 and TMS8.
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Western blot analysis of PmNramp isotypes 
Both the water soluble and the membrane-bound proteins from P. marinus were 
used in Western blot. The parasite cells are ruptured by vortexing together with glass 
beads. The soluble phase is stored in 50 mM Tris-HCl, pH 7.4 and the membrane 
enriched section was dissolved first in the same Tris buffer containing 1% Triton X-100, 
and then SDS sample buffer . The amount of protein used in Western blot is normalized 
to cell number. P. marinus cells were cultured in standard culture medium [191] and the 
cell number used in protein extraction is calculated based on OD600 as described in 
Chapter 2. For water soluble fraction, 1 ml buffer was used to extract protein from 12 x 
108 cells; for membrane-bound fraction, 1 ml buffer was used to dissolve membrane 
protein from 30 x 108 cells. 27 μl protein extracts were loaded for PmNramp1 and 
PmNramp2 western blot, and 18 μl extracts were loaded for PmNramp3 Western blot. 
IFAs in P. marinus cells  
After confirming the specificity of the IgG, IFAs were performed in P. marinus 
cells at exponential growth and stationary phase. At both stages, parasite cells were 
challenged with 0.02 mg/ml DFO for one day before the cells were harvested for IFAs. P. 
marinus cells were fixed in culture medium with 3% formaldehyde for 40 min at room 
temperature, then washed with PBS twice, followed by permeabilization in PBS 
containing 0.1% Triton X-100 for 30 min. Cells were washed in PBS before blocked with 
3% BSA in PBS for 1 hour at room temperature. Cells were incubated with purified IgG 
in PBS containing 3% BSA in 1:50 dilution for 1h at room temperature. After three 
washes with PBS for 5 minutes, cells were incubated with FITC-conjugated donkey anti-
rabbit IgG (Invitrogen, Carlsbad, CA) in PBS containing 3% BSA in 1:1000 dilution for 
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1 h at room temperature. Cells were washed three times with PBS for 5 minutes. After the 
nucleus staining with DAPI (Invitrogen, Carlsbad, CA) in 1:1000 dilution for 10 minutes 
followed by 3 washed in PBS, the cells were mounted on immunofluorescence slides 
(Thermo Scientific). The slides were examined using Nikon Eclipse E800 fluorescence 
microscope, and images of the cells were taken with SPOT RT2540 camera (Diagnostic 
Instruments, INC., Sterling Heights, MI). 
RESULTS 
Western blot on parasite lysates using purified PmNramp IgG 
 Western blot analysis using IgG purified from anti-serum against selected 
PmNramp1 peptides recognize a single band in P. marinus membrane-bound protein 
fraction (Fig. 33 A). No specific bands were detected in soluble fraction of the protein. In 
order to test the specificity of the IgG against the PmNramp1 peptide, membrane-bound 
protein from yeast cell fet3fet4 transformed with PmNramp1-HA was used as a reference. 
Both the IgG and anti-HA antibody show a smear signal in the same position. 
For PmNramp2 western blot, no bands were detected in western blot using 
purified IgG in both the soluble and the detergent phase. A dot blot using the antigen 
peptide showed signals with different intensities consistent with the amount of peptide 
applied. BSA serves as negative controls in the dot blot (Fig. 33 B). The negative result 
in detection of PmNramp2 in western blot, together with the detection of PmNramp2 
peptide by the IgG, indicated that PmNramp2 may not be expressed as protein in 
trophozoites under this condition. 
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For PmNramp3 IgG western blot, a series of bands were detected for the 
membrane-fraction protein extract. It is known that Nramp proteins can be carbohydrate 
modified. The bands with different sizes can be the isomers during the carbohydrate 
modification process. No bands were detected using pre-immune serum and in the 
soluble fraction of the protein (Fig. 33 C).   The amount of the protein loaded for 
PmNramp3 is half of that in PmNramp1 and PmNramp2 western blot, but the PmNramp3 
bands shows a higher intensity compared to PmNramp1. Therefore, PmNramp3 is 
expressed in the highest level. The predicted size for PmNramp3 protein is 60 KDa, 
which is much smaller than the indicated size in the Western blot. The carbohydrate 
modification and the highly hydrophobic character of the membrane protein may cause 


















Fig. 33. Western blot analysis of PmNramp isotypes using purified IgG 
A. Western blots of PmNramp1. Lane 1, detergent extraction of P. marinus protein; lane 
2, water-soluble protein from P. marinus; lane 3, membrane protein extracted from 
fet3fet4 transformed with HA-tagged PmNramp1, probed with PmNramp1 IgG; lane 4, 
same as lane 3 but probed with anti-HA antibody. 
B. Western blots of PmNramp2. Lane 1, detergent extraction of P. marinus protein; lane 
2, water-soluble protein from P. marinus; lane 3, dot blot with PmNramp2 antigen 
peptide and BSA as negative control. 
C. Western blots of PmNramp3. Lane 1, detergent extraction of P. marinus protein 
probed with pre-immune IgG; lane 2, same as lane 1, but probed with purified 
PmNramp3 IgG; lane 3, water-soluble protein from P. marinus.
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Localization of PmNramp3 in log-phase P. marinus trophozoites 
In large log-phase trophozoites, when the parasite underwent schizogony, 
PmNramp3 seemed to localize on the dividing boundary of the cell; when the parasite 
proliferate by binary fission (indicated by two nuclei stained with DAPI), the protein 








Fig. 34. Localization of PmNramp3 in log-phase P. marinus by fluorescence 
microscopy. 
IFAs in extracellular P. marinus cells at the exponential growing stage using purified 
anti-PmNramp3 rabbit IgG as primary antibodies and FITC-conjugated anti-rabbit IgG as 
secondary antibodies. Nucleic dye DAPI was used to reveal the location of nuclei. In 
non-permeabilized parasite cells dividing by schizogony, PmNramp3 seemed to be on the 
dividing boundary. For log-phase parasites in the process of binary fission, PmNramp3 


















The western blot of PmNramp1 using purified anti-PmNramp1 IgG detected a 
band corresponding to a protein with a molecular weight much smaller than expected. To 
examine the possibility that other protein different from PmNramp might contain a 
similar peptide that justified cross-reactivity in P. marinus, a search for a protein with a 
similar antigenic peptide was performed. In the P. marinus genome archive, the NCBI 
tBLASTn program (Search translated nucleotide database using a protein query, 
http://blast.ncbi.nlm.nih.gov/Blast.cgi?PROGRAM=tblastn&BLAST_PROGRAMS=tbla
stn&PAGE_TYPE=BlastSearch&SHOW_DEFAULTS=on&LINK_LOC=blasthome) 
was launched using the PmNramp1 antigenic peptide as query. Two hits were obtained, 
and one of them is PmNramp1. The other one is PmNramp2 that has a stretch of peptide 
sharing 50% identity to the query. Therefore, we concluded that the higher mobility 
(apparent smaller size) of the protein as indicated by the western blot, could be the result 
of anomalous protein migration due to the particularly high number of hydrophobic 
domains. Alternatively, the PmNramp1 protein could have been degraded in the parasite, 
and the band detected was actually part of the protein. However, it may be worthwhile to 
validate the specificity of anti-PmNramp1 antibody by using the antibody against other 
potential epitopes in the recombinant protein. 
In yeast, the PmNramp3 protein was not targeted to cell peripheral before the 
domain swapping (Chapter 4). The subcellular localization of PmNramp3 also showed a 
different pattern in P. marinus trophozoites as compared to the transformed yeast cells. In 
our preliminary study, PmNramp3, which was expressed poorly in yeast, was localized in 
parasite cell periphery during binary fission. The reason(s) for the discrepancy in the 
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subcellular localizations in the trophozoite and yeast are unclear, and but it becomes clear 
that P. marinus is very different from yeast in the various aspects of its complex life 
stages. As an intracellular parasite, P. marinus has co-evolved with its host, which is not 
the case for S. cerevisiae. Besides, the multiple modes of proliferation are also distinct 
between the two organisms. S. cerevisiae divides mostly by budding, but not schizogony 
or binary fission as P. marinus. Therefore, the protein regulation and targeting systems in 
the two organisms may be also very different, and the functional studies in an 
heterologous system such as yeast might not fully reflect the actual mechanisms that take 
place in the parasite. 
The function of PmNramp2 remains unresolved. No functional data about 
PmNramp2 could be obtained by yeast complementation, because no PmNramp2 
transcript was detected in yeast cells. Previous data showed a constitutive transcription of 
PmNramp2 RNA in P. marinus, while western blot indicated PmNramp2 is not translated 
under this particular life stage. It is noteworthy that the PmNramp2 RNA has a 3’UTR 
over 1000bp long (Chapter 2), and it become an interesting question whether this 
extensive 3’UTR might be involved in translational regulation. In addition, the 
PmNramp2 protein sequence was predicted to have a signal peptide targeted to 
chloroplasts (Chapter 2). Several lines of evidence supported the existence of a putative 
plastid in Perkinsus spp. [280-282] and several plastid-related pathways were identified 
in P. marinus EST database [217], however, it still not clear yet if P. marinus 
trophozoites do have plastid, and if this organelle only appear in certain life stage(s).  
Localization of PmNramp1 and PmNramp3 remained unchanged upon DFO 
exposure, despite the fact that it can cause growth inhibition [11]. It may implies that 
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other redundant iron uptake pathways are up-regulated, or alternatively that from an 
energy consumption standpoint the inhibition in growth (up to 10%) at the DFO 
concentration tested is not dramatic enough to alter PmNramp trafficking. Thus, a higher 
concentration of DFO should be tested in future studies to examine this possibility, and 
investigate the impact of iron starvation on the subcellular localization of the PmNramp 
proteins. 
In a non-synchronized P. marinus culture in the exponential growth phase, the 
parasite displays multiple cell division mechanisms, including schizogony and binary 
fission [3, 279]. Our observations are consistent with the report that schizogony is the 
most common way of proliferation. Our preliminary data on subcellular localization of 
Nramp isotypes suggests a role of PmNramp3 in the cell division process, and therefore, 
the targeting of PmNramp3 protein should be tightly controlled. During proliferation, 
parasite cells undergo an active process in which a number of enzymes are involved and 
numerous metabolites are generated. One of the enzymes is the ribonucleotide reductase 
(RR), an iron-dependent enzyme that converts ribonucleotides (NTPs) into 
deoxyribonucleotides (dNTPs) for DNA synthesis [283]. Therefore, iron is highly 
demanded during DNA duplication. On the other hand, abundant ROS are generated 
during the cell proliferation process and in addition to damage to DNA, membrane 
structures, and proteins, ROS can also interfere with the cell cycle [284]. Therefore, the 
activity of the antioxidant pathway has to be maintained and even enhanced during this 
process, and it is noteworthy that P. marinus trophozoites express several anti-oxidative 
pathway components [217], among which two SOD isotypes are iron-containing 
enzymes[14, 16, 285]. Thus, it is possible that PmNramp3 localizes on the cell membrane 
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during binary fission to facilitate rapid iron acquisition for both the nutrient supply and 
antioxidant protection. Another connection between iron transporters and cell division in 
protozoan parasites can be seen in Leishmania. The ferrous iron transporter LIT is an 
important player for iron acquisition by Leishmania amastigotes. The LIT knockout 
parasite has no significant effect on differentiation of promastigotes into amastigotes, but 
it abolishes amastigote division and the parasite virulence, indicating that LIT has a 
critical role at the intracellular stage [106]. The exact localization of PmNramp isotypes 
awaits further investigation. Nevertheless, the data in PmNramp3 localization is 
consistent with the importance of iron for P. marinus survival and growth.  
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CHAPTER 7 SUMMARY AND FUTURE DIRECTIONS 
Functional studies of PmNramp isotypes 
P. marinus has three Nramp isotypes with distinct gene organizations. All the 
PmNramp RNA is trans-spliced with a splicing leader sharing a high similarity with 
dinoflagellates (Chapter 2). PmNramp1, but not PmNramp2 and PmNramp3 can 
complement iron uptake activity in the yeast mutant fet3fet4. The failure of 
complementation of PmNramp2 and PmNrmap3 in the complementation assay could 
result from difficulties in their expression in a heterologous system. However, the 
chimeric PmNramp3 with PmNramp1 N- and C- termini was able to complement iron 
uptake in the mutant yeast. The proposed 3D structure of PmNramp1 provides a 
mechanistic basis for iron acquisition via PmNramp1 (Chapter 5). A phylogenetic 
analysis suggested that all the three PmNramp isotypes are archetype. The protein 
sequence divergence among PmNramp isotypes was not related to diversification of 
critical functional elements, which remained constrained by purifying selection. 
Therefore, the function indicated by yeast complementation as iron transporter for both 
PmNramp1 and PmNramp3 is consistent with the phylogeny prediction (Chapter 3). The 
IFAs in P. marinus is ongoing, but a preliminary study showed distinct localization of the 
PmNramp isotypes in the cultured trophozoites, which appeared to relate to the cell 
division mode. Further, this study showed a plasma membrane localization of PmNramp3 
during parasite binary fission (Chapter 6).  
It has been reported that P. marinus requires iron for in vitro cell growth [11] and in 
vivo infection [Gauthier and Vasta, unpublished; [10]]; however, no information about P. 
marinus iron acquisition pathways was available until the demonstration of iron uptake 
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activity of PmNramp1 and chimeric PmNramp3 by yeast complementation (Chapter 4) in 
this study. The results obtained in this study contributed to the renewal of NSF grant that 
supported it, and the continuing financial support will enable the completion of the 
functional study in PmNramp isotypes. 
Based on the literature, Nramp homologs are able to transport a wide range of 
divalent metals, with a high affinity to iron and manganese [286]. In this study, however, 
we were unable to confirm manganese transport by the PmNramp isotypes by 
complementation of the smf1smf2 yeast mutant. In the future, the yeast mutant 
smf1Δsmf2Δsod2Δ could be used to test the potential manganese transport by PmNramp1, 
since the triple mutant has a higher demand for manganese as compared to the double 
mutant smf1smf2 [253]. Alternatively, the metal (iron and manganese) accumulation in 
yeast transformed with PmNramp isotypes can be examined by inductively coupled 
plasma-MS (ICP-MS). No data about PmNramp2 transport substrate was obtained, since 
PmNramp2 could not be expressed in yeast cells. Electrophysiology studies in Xenopus 
oocytes may be enable the identification of the transport substrate(s) of PmNramp 
isotypes, including PmNramp2.  
The subcellular localization of PmNramp3 in P. marinus during parasite binary 
fission indicated important roles of the transport during cell division. The hypothesis can 
be PmNramp3 is trafficked to the plasma membrane for the uptake of exogenous iron. 
For better understanding of PmNramp isotype localization, new antibodies directly 
conjugated with FITC can be generated against selected portions of the PmNramp 
isotypes produced as recombinant proteins. Another approach to test if the PmNramp 
isotypes are critical for parasite division is by monitoring parasite growth after knock-
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down or knock-out of PmNramp genes. Despite the fact that the knock-down or knock-
out techniques for P. marinus are not yet available, the developed transfection system 
[190] and the success in gene knockdown in Giardia using morpholinos [287] may open 
the new avenues to the development of new molecular tools for research in P. marinus. 
Domain swapping as a novel approach for functional studies of protozoan Nramp in 
heterologous systems 
Heterologous expression systems have long been the methodology for functional 
study of Nramp homologs. However, expression of Nramp homologs in heterologous 
systems can be problematic. To overcome this technical problem, substitution of Nramp 
N- and C-termini has been applied to facilitate the expression [257, 260].  Based on the 
data in Chapter 3, domain swapping can have an impact on both Nramp protein 
expression efficiency and protein trafficking. The success of PmNramp1 expression in 
yeast indicated that N- and C-termini of PmNramp1 may serve as the substitutions in 
other protozoan Nramp homologs that cannot be properly expressed in yeast 
complementation assays. 
P. marinus and oyster hemocyte interaction: the “tug-of-war” for iron 
Our preliminary data indicated that Easter oyster C. virginica can express two 
different Nramp isotypes, and one of which is up-regulated in oyster hemocytes when the 
oyster is challenged by LPS. With the findings of PmNramp isotypes as iron transporters, 
P. marinus and oyster hemocytes may serve as a model to study the “tug-of-war” for iron 
between host and protozoan parasites. As mentioned before, in Leishmania amastigotes, 
LIT knockout abolishes amastigote division and the parasite virulence, and LIT 
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expression is accelerated under iron depletion conditions, such as expression of host 
Nramp1 [106], suggesting competition for iron between LIT and host Nramp. The 
function of LIT seems to potentially overlap with the function of PmNamp3 in the aspect 
of parasite proliferation. In order to test the function of PmNramp isotypes in P. marinus 
and oyster hemocyte interaction, immunostaining of PmNramp3 and other PmNramp 
isotypes after phagocytosis of P. marinus by oyster hemocytes may be performed. The 
identification of PmNramp isotypes as iron transporters and the presence of host Nramp 
after detection of infection suggested that P. marinus trophozoites and oyster hemocyte 
may serve as a model system for the study of tug-off-war for iron between host and 
intracellular parasites. 
Other potential iron uptake pathways in P. marinus 
 Besides further investigation of PmNramp functions, the data included in the 
dissertation also raised a number of other questions. It seemed that DFO challenge did 
not seem to change the trafficking of PmNramp isotypes despite the obvious inhibition in 
parasite growth. This observation led to the hypothesis that there other iron uptake 
pathways might be functional in P. marinus. It is worth to mention that the defined 
culture medium is rich in iron (1.7 mg/ml ferritin), and when there is no increased need 
for iron, a potential low-affinity iron transporter may be enough for the iron supply in the 
parasite. In addition, two homologs of facilitator of iron transport (Accession number 
XM_002764818 and XM_002781371) were annotated in P. marinus genome data base. 
P. marinus genomic organization and post-transcription regulations 
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The identification of SL in P. marinus and the lack of transcriptional regulation in 
the tested genes opened some interesting questions about P. marinus genomic 
organization. The presence of SL and the lack of transcription regulation suggest 
polycistronic transcription in P. marinus, which means genes are organized in different 
units and the genes in the same unit are transcribed into polycistronic RNA precursors. 
The identification of the transcription starting sites in P. marinus chromosomes, and a 
rigorous investigation of P. marinus genome organization may provide a detailed picture 
about the biology of the parasite. Noticeably, transcriptional regulation in P. marinus was 
shown in a trans-spliced gene. Transcript of P. marinus cyclins isotypes Pmacyclin1 was 
significantly increased when the cells were actively dividing [288]. There are two 
hypothetic explanations for the increased transcript: (a) upregulation of transcription, and 
(b) increased RNA stability as a post-transcriptional regulation. For genes lack of 
transcriptional regulation, the importance of post-transcriptional regulation that including 
RNA processing and export, RNAi, RNA stability and translation regulation [289] 
becomes obvious. No annotation of a complete RNAi machinery in the P. marinus 
genome. Our data in PmNramp2 provided a potential example of translational regulation. 
In cultured P. marinus trophozoites, PmNramp2 is transcribed, but no protein expression 
was detected by Western blot. The PmNramp2 gene structure has one unique feature 
compared to PmNramp1 and PmNramp3. The PmNramp2 transcript has a 3’-UTR about 
1k bps, much longer than the PmNramp1 and PmNramp3 3’-UTRs, and it could be 
possible that the PmNramp2 3’UTR plays a role in translation. In Leishmania and 
trypanosomes, 3’-UTRs seemed to be the origination site of translation regulation, and 
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